{"cells":[{"cell_type":"markdown","source":["RDD Implementation"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"07f4b86c-120f-46df-beb0-ef40c02c5808"}}},{"cell_type":"markdown","source":["Installing Bokeh that will be used for visualization"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"fca8d3c8-a299-4040-b1e8-2b7d6648f57a"}}},{"cell_type":"code","source":["%pip install bokeh"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"82a06c4b-3c41-4420-9c05-ddb67424491a"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Python interpreter will be restarted.\nCollecting bokeh\n  Downloading bokeh-2.4.2-py3-none-any.whl (18.5 MB)\nCollecting PyYAML>=3.10\n  Downloading PyYAML-6.0-cp38-cp38-manylinux_2_5_x86_64.manylinux1_x86_64.manylinux_2_12_x86_64.manylinux2010_x86_64.whl (701 kB)\nRequirement already satisfied: pillow>=7.1.0 in /databricks/python3/lib/python3.8/site-packages (from bokeh) (8.2.0)\nRequirement already satisfied: tornado>=5.1 in /databricks/python3/lib/python3.8/site-packages (from bokeh) (6.1)\nCollecting typing-extensions>=3.10.0\n  Downloading typing_extensions-4.2.0-py3-none-any.whl (24 kB)\nRequirement already satisfied: packaging>=16.8 in /databricks/python3/lib/python3.8/site-packages (from bokeh) (20.9)\nRequirement already satisfied: numpy>=1.11.3 in /databricks/python3/lib/python3.8/site-packages (from bokeh) (1.20.1)\nRequirement already satisfied: Jinja2>=2.9 in /databricks/python3/lib/python3.8/site-packages (from bokeh) (2.11.3)\nRequirement already satisfied: MarkupSafe>=0.23 in /databricks/python3/lib/python3.8/site-packages (from Jinja2>=2.9->bokeh) (2.0.1)\nRequirement already satisfied: pyparsing>=2.0.2 in /databricks/python3/lib/python3.8/site-packages (from packaging>=16.8->bokeh) (2.4.7)\nInstalling collected packages: typing-extensions, PyYAML, bokeh\nSuccessfully installed PyYAML-6.0 bokeh-2.4.2 typing-extensions-4.2.0\nPython interpreter will be restarted.\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Python interpreter will be restarted.\nCollecting bokeh\n  Downloading bokeh-2.4.2-py3-none-any.whl (18.5 MB)\nCollecting PyYAML>=3.10\n  Downloading PyYAML-6.0-cp38-cp38-manylinux_2_5_x86_64.manylinux1_x86_64.manylinux_2_12_x86_64.manylinux2010_x86_64.whl (701 kB)\nRequirement already satisfied: pillow>=7.1.0 in /databricks/python3/lib/python3.8/site-packages (from bokeh) (8.2.0)\nRequirement already satisfied: tornado>=5.1 in /databricks/python3/lib/python3.8/site-packages (from bokeh) (6.1)\nCollecting typing-extensions>=3.10.0\n  Downloading typing_extensions-4.2.0-py3-none-any.whl (24 kB)\nRequirement already satisfied: packaging>=16.8 in /databricks/python3/lib/python3.8/site-packages (from bokeh) (20.9)\nRequirement already satisfied: numpy>=1.11.3 in /databricks/python3/lib/python3.8/site-packages (from bokeh) (1.20.1)\nRequirement already satisfied: Jinja2>=2.9 in /databricks/python3/lib/python3.8/site-packages (from bokeh) (2.11.3)\nRequirement already satisfied: MarkupSafe>=0.23 in /databricks/python3/lib/python3.8/site-packages (from Jinja2>=2.9->bokeh) (2.0.1)\nRequirement already satisfied: pyparsing>=2.0.2 in /databricks/python3/lib/python3.8/site-packages (from packaging>=16.8->bokeh) (2.4.7)\nInstalling collected packages: typing-extensions, PyYAML, bokeh\nSuccessfully installed PyYAML-6.0 bokeh-2.4.2 typing-extensions-4.2.0\nPython interpreter will be restarted.\n"]}}],"execution_count":0},{"cell_type":"markdown","source":["Setting up the variables that controls the entire notebook for reusability"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"bc763bac-139f-4129-9faa-a3705fa589a5"}}},{"cell_type":"code","source":["fileA = 'clinicaltrial_2021'\nfileB = 'mesh'\nfileC = 'pharma'\nyear = '2021'"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"55c589e9-dfd9-419c-bd2f-5cf95a1063f3"}},"outputs":[],"execution_count":0},{"cell_type":"markdown","source":["Importing the functions and environments that will be used for the implementation and visualization"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"f6eacb5d-585b-406d-a88f-74646e14729c"}}},{"cell_type":"code","source":["import calendar\nfrom bokeh.io import output_file, show\nfrom bokeh.plotting import figure\nfrom bokeh.io import output_notebook\nfrom bokeh.embed import components, file_html\nfrom bokeh.resources import CDN\nfrom bokeh.core.properties import value\nfrom matplotlib import pyplot as plt"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"23c95558-c5c4-4c38-bc33-fd51a4ab3938"}},"outputs":[],"execution_count":0},{"cell_type":"markdown","source":["Creation of clinicaltrial's (fileA) RDD from the exiting dataframe"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"27a33a75-cc1a-4ed9-83cd-884083e86c73"}}},{"cell_type":"code","source":["file_location = \"/FileStore/tables/\"+fileA+\".csv\"\nfile_type = \"csv\"\n\ninfer_schema = \"True\"\nfirst_row_is_header = \"True\"\ndelimiter = \"|\"\n\nclinicaltrialdf = spark.read.format(file_type) \\\n  .option(\"inferSchema\", infer_schema) \\\n  .option(\"header\", first_row_is_header) \\\n  .option(\"sep\", delimiter) \\\n  .load(\"/FileStore/tables/\"+fileA+\".csv\")\n\nclinicaltrialRDD1=clinicaltrialdf.rdd\nclinicaltrialRDD1.take(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"65595d5e-2b82-4df6-b1be-a0baff69a931"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[3]: [Row(Id='NCT02758028', Sponsor='The University of Hong Kong', Status='Recruiting', Start='Aug 2005', Completion='Nov 2021', Type='Interventional', Submission='Apr 2016', Conditions=None, Interventions=None),\n Row(Id='NCT02751957', Sponsor='Duke University', Status='Completed', Start='Jul 2016', Completion='Jul 2020', Type='Interventional', Submission='Apr 2016', Conditions='Autistic Disorder,Autism Spectrum Disorder', Interventions=None),\n Row(Id='NCT02758483', Sponsor='Universidade Federal do Rio de Janeiro', Status='Completed', Start='Mar 2017', Completion='Jan 2018', Type='Interventional', Submission='Apr 2016', Conditions='Diabetes Mellitus', Interventions=None),\n Row(Id='NCT02759848', Sponsor='Istanbul Medeniyet University', Status='Completed', Start='Jan 2012', Completion='Dec 2014', Type='Observational', Submission='May 2016', Conditions='Tuberculosis,Lung Diseases,Pulmonary Disease', Interventions=None),\n Row(Id='NCT02758860', Sponsor='University of Roma La Sapienza', Status='Active, not recruiting', Start='Jun 2016', Completion='Sep 2020', Type='Observational [Patient Registry]', Submission='Apr 2016', Conditions='Diverticular Diseases,Diverticulum,Diverticulosis', Interventions=None)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[3]: [Row(Id='NCT02758028', Sponsor='The University of Hong Kong', Status='Recruiting', Start='Aug 2005', Completion='Nov 2021', Type='Interventional', Submission='Apr 2016', Conditions=None, Interventions=None),\n Row(Id='NCT02751957', Sponsor='Duke University', Status='Completed', Start='Jul 2016', Completion='Jul 2020', Type='Interventional', Submission='Apr 2016', Conditions='Autistic Disorder,Autism Spectrum Disorder', Interventions=None),\n Row(Id='NCT02758483', Sponsor='Universidade Federal do Rio de Janeiro', Status='Completed', Start='Mar 2017', Completion='Jan 2018', Type='Interventional', Submission='Apr 2016', Conditions='Diabetes Mellitus', Interventions=None),\n Row(Id='NCT02759848', Sponsor='Istanbul Medeniyet University', Status='Completed', Start='Jan 2012', Completion='Dec 2014', Type='Observational', Submission='May 2016', Conditions='Tuberculosis,Lung Diseases,Pulmonary Disease', Interventions=None),\n Row(Id='NCT02758860', Sponsor='University of Roma La Sapienza', Status='Active, not recruiting', Start='Jun 2016', Completion='Sep 2020', Type='Observational [Patient Registry]', Submission='Apr 2016', Conditions='Diverticular Diseases,Diverticulum,Diverticulosis', Interventions=None)]"]}}],"execution_count":0},{"cell_type":"markdown","source":["Creation of clinicaltrials RDD using sc.textFile"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"53f07d1e-28ed-4886-adc4-f0e9150308fa"}}},{"cell_type":"code","source":["clinicaltrialRDD = sc.textFile(\"DBFS:/FileStore/tables/\"+fileA+\".csv\")\nclinicaltrialRDD.take(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"904773a0-cac2-4901-b430-3d498852ecf3"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[4]: ['Id|Sponsor|Status|Start|Completion|Type|Submission|Conditions|Interventions',\n 'NCT02758028|The University of Hong Kong|Recruiting|Aug 2005|Nov 2021|Interventional|Apr 2016||',\n 'NCT02751957|Duke University|Completed|Jul 2016|Jul 2020|Interventional|Apr 2016|Autistic Disorder,Autism Spectrum Disorder|',\n 'NCT02758483|Universidade Federal do Rio de Janeiro|Completed|Mar 2017|Jan 2018|Interventional|Apr 2016|Diabetes Mellitus|',\n 'NCT02759848|Istanbul Medeniyet University|Completed|Jan 2012|Dec 2014|Observational|May 2016|Tuberculosis,Lung Diseases,Pulmonary Disease|']","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[4]: ['Id|Sponsor|Status|Start|Completion|Type|Submission|Conditions|Interventions',\n 'NCT02758028|The University of Hong Kong|Recruiting|Aug 2005|Nov 2021|Interventional|Apr 2016||',\n 'NCT02751957|Duke University|Completed|Jul 2016|Jul 2020|Interventional|Apr 2016|Autistic Disorder,Autism Spectrum Disorder|',\n 'NCT02758483|Universidade Federal do Rio de Janeiro|Completed|Mar 2017|Jan 2018|Interventional|Apr 2016|Diabetes Mellitus|',\n 'NCT02759848|Istanbul Medeniyet University|Completed|Jan 2012|Dec 2014|Observational|May 2016|Tuberculosis,Lung Diseases,Pulmonary Disease|']"]}}],"execution_count":0},{"cell_type":"markdown","source":["Removing the clinicaltrials Header"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"cac1817a-7c6c-49f4-82d9-6bd9ff3ca411"}}},{"cell_type":"code","source":["headerA = clinicaltrialRDD.first()\nHeaderfileARDD = clinicaltrialRDD.filter(lambda line: line!= headerA)\nHeaderfileARDD.take(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"02af80b4-6328-4afa-b3bc-268e305c25c8"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[5]: ['NCT02758028|The University of Hong Kong|Recruiting|Aug 2005|Nov 2021|Interventional|Apr 2016||',\n 'NCT02751957|Duke University|Completed|Jul 2016|Jul 2020|Interventional|Apr 2016|Autistic Disorder,Autism Spectrum Disorder|',\n 'NCT02758483|Universidade Federal do Rio de Janeiro|Completed|Mar 2017|Jan 2018|Interventional|Apr 2016|Diabetes Mellitus|',\n 'NCT02759848|Istanbul Medeniyet University|Completed|Jan 2012|Dec 2014|Observational|May 2016|Tuberculosis,Lung Diseases,Pulmonary Disease|',\n 'NCT02758860|University of Roma La Sapienza|Active, not recruiting|Jun 2016|Sep 2020|Observational [Patient Registry]|Apr 2016|Diverticular Diseases,Diverticulum,Diverticulosis|']","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[5]: ['NCT02758028|The University of Hong Kong|Recruiting|Aug 2005|Nov 2021|Interventional|Apr 2016||',\n 'NCT02751957|Duke University|Completed|Jul 2016|Jul 2020|Interventional|Apr 2016|Autistic Disorder,Autism Spectrum Disorder|',\n 'NCT02758483|Universidade Federal do Rio de Janeiro|Completed|Mar 2017|Jan 2018|Interventional|Apr 2016|Diabetes Mellitus|',\n 'NCT02759848|Istanbul Medeniyet University|Completed|Jan 2012|Dec 2014|Observational|May 2016|Tuberculosis,Lung Diseases,Pulmonary Disease|',\n 'NCT02758860|University of Roma La Sapienza|Active, not recruiting|Jun 2016|Sep 2020|Observational [Patient Registry]|Apr 2016|Diverticular Diseases,Diverticulum,Diverticulosis|']"]}}],"execution_count":0},{"cell_type":"markdown","source":["Creating mesh (fileB) RDD using the existing dataframe"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"c951fce7-a9ac-4dc5-a854-384998b37242"}}},{"cell_type":"code","source":["file_location = \"/FileStore/tables/\"+fileB+\".csv\"\nfile_type = \"csv\"\n\ninfer_schema = \"True\"\nfirst_row_is_header = \"True\"\ndelimiter = \",\"\n\nmeshdf = spark.read.format(file_type) \\\n  .option(\"inferSchema\", infer_schema) \\\n  .option(\"header\", first_row_is_header) \\\n  .option(\"sep\", delimiter) \\\n  .load(\"/FileStore/tables/\"+fileB+\".csv\")\n\nmeshRDD1=meshdf.rdd\nmeshRDD1.take(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"80efc4eb-9443-45b4-9cb5-b07625626df6"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[6]: [Row(term='Calcimycin', tree='D03.633.100.221.173'),\n Row(term='A-23187', tree='D03.633.100.221.173'),\n Row(term='Temefos', tree='D02.705.400.625.800'),\n Row(term='Temefos', tree='D02.705.539.345.800'),\n Row(term='Temefos', tree='D02.886.300.692.800')]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[6]: [Row(term='Calcimycin', tree='D03.633.100.221.173'),\n Row(term='A-23187', tree='D03.633.100.221.173'),\n Row(term='Temefos', tree='D02.705.400.625.800'),\n Row(term='Temefos', tree='D02.705.539.345.800'),\n Row(term='Temefos', tree='D02.886.300.692.800')]"]}}],"execution_count":0},{"cell_type":"markdown","source":["Creating mesh (fileB) RDD using a second method (sc.textfile)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"d71ed61a-153b-42d7-b030-69fe4d80f0e2"}}},{"cell_type":"code","source":["meshRDD= sc.textFile(\"DBFS:/FileStore/tables/\"+fileB+\".csv\")\nmeshRDD.take(10)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"ab7558af-34e7-4dda-8b02-8251876e300a"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[7]: ['term,tree',\n 'Calcimycin,D03.633.100.221.173',\n 'A-23187,D03.633.100.221.173',\n 'Temefos,D02.705.400.625.800',\n 'Temefos,D02.705.539.345.800',\n 'Temefos,D02.886.300.692.800',\n 'Abate,D02.705.400.625.800',\n 'Abate,D02.705.539.345.800',\n 'Abate,D02.886.300.692.800',\n 'Difos,D02.705.400.625.800']","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[7]: ['term,tree',\n 'Calcimycin,D03.633.100.221.173',\n 'A-23187,D03.633.100.221.173',\n 'Temefos,D02.705.400.625.800',\n 'Temefos,D02.705.539.345.800',\n 'Temefos,D02.886.300.692.800',\n 'Abate,D02.705.400.625.800',\n 'Abate,D02.705.539.345.800',\n 'Abate,D02.886.300.692.800',\n 'Difos,D02.705.400.625.800']"]}}],"execution_count":0},{"cell_type":"markdown","source":["Removing the Header of mesh (fileB) RDD"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"24234d32-3129-4fae-81b0-9d74da8ea326"}}},{"cell_type":"code","source":["headerB = meshRDD.first()\nHeaderfileBRDD = meshRDD.filter(lambda line: line!= headerB)\nHeaderfileBRDD.take(10)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"f84ee20b-63d6-4948-9ade-8fd61dd73b3d"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[8]: ['Calcimycin,D03.633.100.221.173',\n 'A-23187,D03.633.100.221.173',\n 'Temefos,D02.705.400.625.800',\n 'Temefos,D02.705.539.345.800',\n 'Temefos,D02.886.300.692.800',\n 'Abate,D02.705.400.625.800',\n 'Abate,D02.705.539.345.800',\n 'Abate,D02.886.300.692.800',\n 'Difos,D02.705.400.625.800',\n 'Difos,D02.705.539.345.800']","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[8]: ['Calcimycin,D03.633.100.221.173',\n 'A-23187,D03.633.100.221.173',\n 'Temefos,D02.705.400.625.800',\n 'Temefos,D02.705.539.345.800',\n 'Temefos,D02.886.300.692.800',\n 'Abate,D02.705.400.625.800',\n 'Abate,D02.705.539.345.800',\n 'Abate,D02.886.300.692.800',\n 'Difos,D02.705.400.625.800',\n 'Difos,D02.705.539.345.800']"]}}],"execution_count":0},{"cell_type":"markdown","source":["Creating pharma (fileC) RDD using the existing dataframe"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"c9de8bba-ba45-400d-8891-f70d5a5796c5"}}},{"cell_type":"code","source":["file_location = \"/FileStore/tables/\"+fileC+\".csv\"\nfile_type = \"csv\"\n\ninfer_schema = \"True\"\nfirst_row_is_header = \"True\"\ndelimiter = \",\"\n\npharmadf = spark.read.format(file_type) \\\n  .option(\"inferSchema\", infer_schema) \\\n  .option(\"header\", first_row_is_header) \\\n  .option(\"sep\", delimiter) \\\n  .load(\"/FileStore/tables/\"+fileC+\".csv\")\n\npharmaRDD1=pharmadf.rdd\npharmaRDD1.take(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"6040b738-1524-4f1b-9300-51451d1a9222"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[9]: [Row(Company='Abbott Laboratories', Parent_Company='Abbott Laboratories', Penalty_Amount='$5,475,000', Subtraction_From_Penalty='$0', Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting='$5,475,000', Penalty_Year=2013, Penalty_Date=20131227, Offense_Group='government-contracting-related offenses', Primary_Offense='False Claims Act and related', Secondary_Offense='kickbacks and bribery', Description=\"Abbott Laboratories agreed to $5.475 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce doctors to implant the company's carotid, biliary and peripheral vascular products.\", Level_of_Government='federal', Action_Type='agency action', Agency='Justice Department Civil Division', Civil/Criminal='civil', Prosecution_Agreement=None, Court=None, Case_ID=None, Private_Litigation_Case_Title=None, Lawsuit_Resolution=None, Facility_State=None, City=None, Address=None, Zip=None, NAICS_Code=None, NAICS_Translation=None, HQ_Country_of_Parent='USA', HQ_State_of_Parent='Illinois', Ownership_Structure='publicly traded', Parent_Company_Stock_Ticker='ABT', Major_Industry_of_Parent='pharmaceuticals', Specific_Industry_of_Parent='pharmaceuticals', Info_Source='https://www.justice.gov/opa/pr/abbott-laboratories-pays-us-5475-million-settle-claims-company-paid-kickbacks-physicians', Notes=None),\n Row(Company='Abbott Laboratories Inc.', Parent_Company='AbbVie', Penalty_Amount='$1,500,000,000', Subtraction_From_Penalty='$0', Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting='$1,500,000,000', Penalty_Year=2012, Penalty_Date=20120507, Offense_Group='healthcare-related offenses', Primary_Offense='off-label or unapproved promotion of medical products', Secondary_Offense=None, Description=\"Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company's unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration. The resolution - the second largest payment by a drug company - includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million. Abbott also will be subject to court-supervised probation and reporting obligations for Abbotts CEO and Board of Directors.\", Level_of_Government='federal', Action_Type='agency action', Agency='Food and Drug Administration referral to the Justice Department', Civil/Criminal='civil and criminal', Prosecution_Agreement=None, Court=None, Case_ID=None, Private_Litigation_Case_Title=None, Lawsuit_Resolution=None, Facility_State=None, City=None, Address=None, Zip=None, NAICS_Code=None, NAICS_Translation=None, HQ_Country_of_Parent='USA', HQ_State_of_Parent='Illinois', Ownership_Structure='publicly traded', Parent_Company_Stock_Ticker='ABBV', Major_Industry_of_Parent='pharmaceuticals', Specific_Industry_of_Parent='pharmaceuticals', Info_Source='http://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote', Notes=None),\n Row(Company='Abbott Laboratories Inc.', Parent_Company='AbbVie', Penalty_Amount='$126,500,000', Subtraction_From_Penalty='$0', Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting='$126,500,000', Penalty_Year=2010, Penalty_Date=20101207, Offense_Group='government-contracting-related offenses', Primary_Offense='False Claims Act and related', Secondary_Offense=None, Description='Abbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories Inc. n/k/a Boehringer Ingelheim Roxane Inc. and affiliated entities agreed to pay $421 million to settle False Claims Act allegations, that they engaged in a scheme to report false and inflated prices for numerous pharmaceutical products knowing that federal healthcare programs relied on those reported prices to set payment rates.', Level_of_Government='federal', Action_Type='agency action', Agency='Justice Department Civil Division', Civil/Criminal='civil', Prosecution_Agreement=None, Court=None, Case_ID=None, Private_Litigation_Case_Title=None, Lawsuit_Resolution=None, Facility_State=None, City=None, Address=None, Zip=None, NAICS_Code=None, NAICS_Translation=None, HQ_Country_of_Parent='USA', HQ_State_of_Parent='Illinois', Ownership_Structure='publicly traded', Parent_Company_Stock_Ticker='ABBV', Major_Industry_of_Parent='pharmaceuticals', Specific_Industry_of_Parent='pharmaceuticals', Info_Source='https://www.justice.gov/opa/pr/pharmaceutical-manufacturers-pay-4212-million-settle-false-claims-act-cases', Notes=None),\n Row(Company='Abbott Laboratories Puerto Rico, Inc.', Parent_Company='Abbott Laboratories', Penalty_Amount='$49,045', Subtraction_From_Penalty='$0', Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting='$49,045', Penalty_Year=2009, Penalty_Date=20090305, Offense_Group='employment-related offenses', Primary_Offense='wage and hour violation', Secondary_Offense='Fair Labor Standards Act', Description=None, Level_of_Government='federal', Action_Type='agency action', Agency='Labor Department Wage and Hour Division', Civil/Criminal='civil', Prosecution_Agreement=None, Court=None, Case_ID='1527129', Private_Litigation_Case_Title=None, Lawsuit_Resolution=None, Facility_State='Puerto Rico', City='San Juan', Address=None, Zip=None, NAICS_Code=423450, NAICS_Translation='423450: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers', HQ_Country_of_Parent='USA', HQ_State_of_Parent='Illinois', Ownership_Structure='publicly traded', Parent_Company_Stock_Ticker='ABT', Major_Industry_of_Parent='pharmaceuticals', Specific_Industry_of_Parent='pharmaceuticals', Info_Source='March 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php', Notes='Date and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.'),\n Row(Company='Acclarent Inc.', Parent_Company='Johnson & Johnson', Penalty_Amount='$18,000,000', Subtraction_From_Penalty='$0', Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting='$18,000,000', Penalty_Year=2016, Penalty_Date=20160722, Offense_Group='government-contracting-related offenses', Primary_Offense='False Claims Act and related', Secondary_Offense=None, Description='California-based medical device manufacturer Acclarent Inc., a subsidiary of Johnson & Johnson, agreed to pay $18 million to resolve allegations that the company caused health care providers to submit false claims to Medicare and other federal health care programs by marketing and distributing its sinus spacer product for use as a drug delivery device without Food and Drug Administration approval.', Level_of_Government='federal', Action_Type='agency action', Agency='Justice Department Civil Division', Civil/Criminal='civil', Prosecution_Agreement=None, Court=None, Case_ID=None, Private_Litigation_Case_Title=None, Lawsuit_Resolution=None, Facility_State=None, City=None, Address=None, Zip=None, NAICS_Code=None, NAICS_Translation=None, HQ_Country_of_Parent='USA', HQ_State_of_Parent='New Jersey', Ownership_Structure='publicly traded', Parent_Company_Stock_Ticker='JNJ', Major_Industry_of_Parent='pharmaceuticals', Specific_Industry_of_Parent='pharmaceuticals', Info_Source='https://www.justice.gov/opa/pr/johnson-johnson-subsidiary-acclarent-inc-pays-government-18-million-settle-false-claims-act', Notes=None)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[9]: [Row(Company='Abbott Laboratories', Parent_Company='Abbott Laboratories', Penalty_Amount='$5,475,000', Subtraction_From_Penalty='$0', Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting='$5,475,000', Penalty_Year=2013, Penalty_Date=20131227, Offense_Group='government-contracting-related offenses', Primary_Offense='False Claims Act and related', Secondary_Offense='kickbacks and bribery', Description=\"Abbott Laboratories agreed to $5.475 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce doctors to implant the company's carotid, biliary and peripheral vascular products.\", Level_of_Government='federal', Action_Type='agency action', Agency='Justice Department Civil Division', Civil/Criminal='civil', Prosecution_Agreement=None, Court=None, Case_ID=None, Private_Litigation_Case_Title=None, Lawsuit_Resolution=None, Facility_State=None, City=None, Address=None, Zip=None, NAICS_Code=None, NAICS_Translation=None, HQ_Country_of_Parent='USA', HQ_State_of_Parent='Illinois', Ownership_Structure='publicly traded', Parent_Company_Stock_Ticker='ABT', Major_Industry_of_Parent='pharmaceuticals', Specific_Industry_of_Parent='pharmaceuticals', Info_Source='https://www.justice.gov/opa/pr/abbott-laboratories-pays-us-5475-million-settle-claims-company-paid-kickbacks-physicians', Notes=None),\n Row(Company='Abbott Laboratories Inc.', Parent_Company='AbbVie', Penalty_Amount='$1,500,000,000', Subtraction_From_Penalty='$0', Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting='$1,500,000,000', Penalty_Year=2012, Penalty_Date=20120507, Offense_Group='healthcare-related offenses', Primary_Offense='off-label or unapproved promotion of medical products', Secondary_Offense=None, Description=\"Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company's unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration. The resolution - the second largest payment by a drug company - includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million. Abbott also will be subject to court-supervised probation and reporting obligations for Abbotts CEO and Board of Directors.\", Level_of_Government='federal', Action_Type='agency action', Agency='Food and Drug Administration referral to the Justice Department', Civil/Criminal='civil and criminal', Prosecution_Agreement=None, Court=None, Case_ID=None, Private_Litigation_Case_Title=None, Lawsuit_Resolution=None, Facility_State=None, City=None, Address=None, Zip=None, NAICS_Code=None, NAICS_Translation=None, HQ_Country_of_Parent='USA', HQ_State_of_Parent='Illinois', Ownership_Structure='publicly traded', Parent_Company_Stock_Ticker='ABBV', Major_Industry_of_Parent='pharmaceuticals', Specific_Industry_of_Parent='pharmaceuticals', Info_Source='http://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote', Notes=None),\n Row(Company='Abbott Laboratories Inc.', Parent_Company='AbbVie', Penalty_Amount='$126,500,000', Subtraction_From_Penalty='$0', Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting='$126,500,000', Penalty_Year=2010, Penalty_Date=20101207, Offense_Group='government-contracting-related offenses', Primary_Offense='False Claims Act and related', Secondary_Offense=None, Description='Abbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories Inc. n/k/a Boehringer Ingelheim Roxane Inc. and affiliated entities agreed to pay $421 million to settle False Claims Act allegations, that they engaged in a scheme to report false and inflated prices for numerous pharmaceutical products knowing that federal healthcare programs relied on those reported prices to set payment rates.', Level_of_Government='federal', Action_Type='agency action', Agency='Justice Department Civil Division', Civil/Criminal='civil', Prosecution_Agreement=None, Court=None, Case_ID=None, Private_Litigation_Case_Title=None, Lawsuit_Resolution=None, Facility_State=None, City=None, Address=None, Zip=None, NAICS_Code=None, NAICS_Translation=None, HQ_Country_of_Parent='USA', HQ_State_of_Parent='Illinois', Ownership_Structure='publicly traded', Parent_Company_Stock_Ticker='ABBV', Major_Industry_of_Parent='pharmaceuticals', Specific_Industry_of_Parent='pharmaceuticals', Info_Source='https://www.justice.gov/opa/pr/pharmaceutical-manufacturers-pay-4212-million-settle-false-claims-act-cases', Notes=None),\n Row(Company='Abbott Laboratories Puerto Rico, Inc.', Parent_Company='Abbott Laboratories', Penalty_Amount='$49,045', Subtraction_From_Penalty='$0', Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting='$49,045', Penalty_Year=2009, Penalty_Date=20090305, Offense_Group='employment-related offenses', Primary_Offense='wage and hour violation', Secondary_Offense='Fair Labor Standards Act', Description=None, Level_of_Government='federal', Action_Type='agency action', Agency='Labor Department Wage and Hour Division', Civil/Criminal='civil', Prosecution_Agreement=None, Court=None, Case_ID='1527129', Private_Litigation_Case_Title=None, Lawsuit_Resolution=None, Facility_State='Puerto Rico', City='San Juan', Address=None, Zip=None, NAICS_Code=423450, NAICS_Translation='423450: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers', HQ_Country_of_Parent='USA', HQ_State_of_Parent='Illinois', Ownership_Structure='publicly traded', Parent_Company_Stock_Ticker='ABT', Major_Industry_of_Parent='pharmaceuticals', Specific_Industry_of_Parent='pharmaceuticals', Info_Source='March 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php', Notes='Date and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.'),\n Row(Company='Acclarent Inc.', Parent_Company='Johnson & Johnson', Penalty_Amount='$18,000,000', Subtraction_From_Penalty='$0', Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting='$18,000,000', Penalty_Year=2016, Penalty_Date=20160722, Offense_Group='government-contracting-related offenses', Primary_Offense='False Claims Act and related', Secondary_Offense=None, Description='California-based medical device manufacturer Acclarent Inc., a subsidiary of Johnson & Johnson, agreed to pay $18 million to resolve allegations that the company caused health care providers to submit false claims to Medicare and other federal health care programs by marketing and distributing its sinus spacer product for use as a drug delivery device without Food and Drug Administration approval.', Level_of_Government='federal', Action_Type='agency action', Agency='Justice Department Civil Division', Civil/Criminal='civil', Prosecution_Agreement=None, Court=None, Case_ID=None, Private_Litigation_Case_Title=None, Lawsuit_Resolution=None, Facility_State=None, City=None, Address=None, Zip=None, NAICS_Code=None, NAICS_Translation=None, HQ_Country_of_Parent='USA', HQ_State_of_Parent='New Jersey', Ownership_Structure='publicly traded', Parent_Company_Stock_Ticker='JNJ', Major_Industry_of_Parent='pharmaceuticals', Specific_Industry_of_Parent='pharmaceuticals', Info_Source='https://www.justice.gov/opa/pr/johnson-johnson-subsidiary-acclarent-inc-pays-government-18-million-settle-false-claims-act', Notes=None)]"]}}],"execution_count":0},{"cell_type":"markdown","source":["Creating Pharma (fileC) RDD using a second method (sc.textfile)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"cc6ede81-cc4a-4d40-92dc-4519b9b1ee7e"}}},{"cell_type":"code","source":["pharmaRDD= sc.textFile(\"DBFS:/FileStore/tables/\"+fileC+\".csv\")\npharmaRDD.take(10)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"e1b936b4-746f-4113-8f54-4404125e4d53"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[10]: ['\"Company\",\"Parent_Company\",\"Penalty_Amount\",\"Subtraction_From_Penalty\",\"Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting\",\"Penalty_Year\",\"Penalty_Date\",\"Offense_Group\",\"Primary_Offense\",\"Secondary_Offense\",\"Description\",\"Level_of_Government\",\"Action_Type\",\"Agency\",\"Civil/Criminal\",\"Prosecution_Agreement\",\"Court\",\"Case_ID\",\"Private_Litigation_Case_Title\",\"Lawsuit_Resolution\",\"Facility_State\",\"City\",\"Address\",\"Zip\",\"NAICS_Code\",\"NAICS_Translation\",\"HQ_Country_of_Parent\",\"HQ_State_of_Parent\",\"Ownership_Structure\",\"Parent_Company_Stock_Ticker\",\"Major_Industry_of_Parent\",\"Specific_Industry_of_Parent\",\"Info_Source\",\"Notes\"',\n '\"Abbott Laboratories\",\"Abbott Laboratories\",\"$5,475,000\",\"$0\",\"$5,475,000\",\"2013\",\"20131227\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"kickbacks and bribery\",\"Abbott Laboratories agreed to $5.475 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce doctors to implant the company\\'s carotid, biliary and peripheral vascular products.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/abbott-laboratories-pays-us-5475-million-settle-claims-company-paid-kickbacks-physicians\",\"\"',\n '\"Abbott Laboratories Inc.\",\"AbbVie\",\"$1,500,000,000\",\"$0\",\"$1,500,000,000\",\"2012\",\"20120507\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company\\'s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration. The resolution - the second largest payment by a drug company - includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million. Abbott also will be subject to court-supervised probation and reporting obligations for Abbotts CEO and Board of Directors.\",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"civil and criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote\",\"\"',\n '\"Abbott Laboratories Inc.\",\"AbbVie\",\"$126,500,000\",\"$0\",\"$126,500,000\",\"2010\",\"20101207\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"Abbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories Inc. n/k/a Boehringer Ingelheim Roxane Inc. and affiliated entities agreed to pay $421 million to settle False Claims Act allegations, that they engaged in a scheme to report false and inflated prices for numerous pharmaceutical products knowing that federal healthcare programs relied on those reported prices to set payment rates.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/pharmaceutical-manufacturers-pay-4212-million-settle-false-claims-act-cases\",\"\"',\n '\"Abbott Laboratories Puerto Rico, Inc.\",\"Abbott Laboratories\",\"$49,045\",\"$0\",\"$49,045\",\"2009\",\"20090305\",\"employment-related offenses\",\"wage and hour violation\",\"Fair Labor Standards Act\",\"\",\"federal\",\"agency action\",\"Labor Department Wage and Hour Division\",\"civil\",\"\",\"\",\"1527129\",\"\",\"\",\"Puerto Rico\",\"San Juan\",\"\",\"\",\"423450\",\"423450: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"March 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\",\"Date and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\"',\n '\"Acclarent Inc.\",\"Johnson & Johnson\",\"$18,000,000\",\"$0\",\"$18,000,000\",\"2016\",\"20160722\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"California-based medical device manufacturer Acclarent Inc., a subsidiary of Johnson & Johnson, agreed to pay $18 million to resolve allegations that the company caused health care providers to submit false claims to Medicare and other federal health care programs by marketing and distributing its sinus spacer product for use as a drug delivery device without Food and Drug Administration approval.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"JNJ\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/johnson-johnson-subsidiary-acclarent-inc-pays-government-18-million-settle-false-claims-act\",\"\"',\n '\"Advanced Medical Optics\",\"Abbott Laboratories\",\"$16,800\",\"$0\",\"$16,800\",\"2004\",\"20040412\",\"employment-related offenses\",\"labor relations violation\",\"\",\"back pay award in unfair labor practices case\",\"federal\",\"agency action\",\"National Labor Relations Board\",\"civil\",\"\",\"\",\"21-CA-36104-001\",\"\",\"\",\"California\",\"Irvine\",\"\",\"92606\",\"333314\",\"333314: Optical Instrument and Lens Manufacturing\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"Extracted from an NLRB dataset covering 1999-2011 downloaded at https://catalog.data.gov/dataset/nlrb-cats-final-c-case-data-bulk-19990101-20110930-in-xml\",\"\"',\n '\"Advanced Neuromodulation Systems, Inc.\",\"Abbott Laboratories\",\"$2,950,000\",\"$0\",\"$2,950,000\",\"2007\",\"20070702\",\"healthcare-related offenses\",\"HHS civil monetary penalties\",\"kickbacks and bribery\",\"The HHS Inspector General announced that Advanced Neuromodulation Systems, Inc.,  a medical device manufacturer specializing in spinal cord stimulation used for pain management, agreed to pay $2.95 million to settle allegations that it paid kickbacks to physicians in violation of the Civil Monetary Penalties Law (CMPL). The company also entered into a 3-year Corporate Integrity Agreement.\",\"federal\",\"agency action\",\"Health & Human Services Department Office of Inspector General\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://oig.hhs.gov/publications/docs/press/2007/ANS%20Press%20Release.pdf\",\"\"',\n '\"Advanced Sterilization Products\",\"Johnson & Johnson\",\"$136,800\",\"$0\",\"$136,800\",\"2014\",\"20140520\",\"environment-related offenses\",\"environmental violation\",\"\",\"The U.S. Environmental Protection Agency announced that an Irvine, Calif. company, Advanced Sterilization Products, has agreed to pay a $136,800 penalty for the sale and distribution of unregistered and misbranded pesticides to veterinary clinics and laboratories nationwide.\",\"federal\",\"agency action\",\"Environmental Protection Agency\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"California\",\"Irvine\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"JNJ\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://archive.epa.gov/epapages/newsroom_archive/newsreleases/8e820317c86e4c5685257cde00717855.html\",\"\"',\n '\"Advanced Sterilization Products, a division of Ethicon Inc.\",\"Johnson & Johnson\",\"$1,200,000\",\"$0\",\"$1,200,000\",\"2013\",\"20131204\",\"safety-related offenses\",\"drug or medical equipment safety violation\",\"\",\"Settlement of a civil money penalty action against Advanced Sterilization Products, a division of Ethicon Inc., a Johnson & Johnson company, and two of ASP\\'s executives alleging that ASP manufactured and distributed adulterated and misbranded sterilization monitoring products.\",\"federal\",\"agency action\",\"Food and Drug Administration\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"California\",\"Irvine\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"JNJ\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm377588.htm\",\"\"']","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[10]: ['\"Company\",\"Parent_Company\",\"Penalty_Amount\",\"Subtraction_From_Penalty\",\"Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting\",\"Penalty_Year\",\"Penalty_Date\",\"Offense_Group\",\"Primary_Offense\",\"Secondary_Offense\",\"Description\",\"Level_of_Government\",\"Action_Type\",\"Agency\",\"Civil/Criminal\",\"Prosecution_Agreement\",\"Court\",\"Case_ID\",\"Private_Litigation_Case_Title\",\"Lawsuit_Resolution\",\"Facility_State\",\"City\",\"Address\",\"Zip\",\"NAICS_Code\",\"NAICS_Translation\",\"HQ_Country_of_Parent\",\"HQ_State_of_Parent\",\"Ownership_Structure\",\"Parent_Company_Stock_Ticker\",\"Major_Industry_of_Parent\",\"Specific_Industry_of_Parent\",\"Info_Source\",\"Notes\"',\n '\"Abbott Laboratories\",\"Abbott Laboratories\",\"$5,475,000\",\"$0\",\"$5,475,000\",\"2013\",\"20131227\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"kickbacks and bribery\",\"Abbott Laboratories agreed to $5.475 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce doctors to implant the company\\'s carotid, biliary and peripheral vascular products.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/abbott-laboratories-pays-us-5475-million-settle-claims-company-paid-kickbacks-physicians\",\"\"',\n '\"Abbott Laboratories Inc.\",\"AbbVie\",\"$1,500,000,000\",\"$0\",\"$1,500,000,000\",\"2012\",\"20120507\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company\\'s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration. The resolution - the second largest payment by a drug company - includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million. Abbott also will be subject to court-supervised probation and reporting obligations for Abbotts CEO and Board of Directors.\",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"civil and criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote\",\"\"',\n '\"Abbott Laboratories Inc.\",\"AbbVie\",\"$126,500,000\",\"$0\",\"$126,500,000\",\"2010\",\"20101207\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"Abbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories Inc. n/k/a Boehringer Ingelheim Roxane Inc. and affiliated entities agreed to pay $421 million to settle False Claims Act allegations, that they engaged in a scheme to report false and inflated prices for numerous pharmaceutical products knowing that federal healthcare programs relied on those reported prices to set payment rates.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/pharmaceutical-manufacturers-pay-4212-million-settle-false-claims-act-cases\",\"\"',\n '\"Abbott Laboratories Puerto Rico, Inc.\",\"Abbott Laboratories\",\"$49,045\",\"$0\",\"$49,045\",\"2009\",\"20090305\",\"employment-related offenses\",\"wage and hour violation\",\"Fair Labor Standards Act\",\"\",\"federal\",\"agency action\",\"Labor Department Wage and Hour Division\",\"civil\",\"\",\"\",\"1527129\",\"\",\"\",\"Puerto Rico\",\"San Juan\",\"\",\"\",\"423450\",\"423450: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"March 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\",\"Date and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\"',\n '\"Acclarent Inc.\",\"Johnson & Johnson\",\"$18,000,000\",\"$0\",\"$18,000,000\",\"2016\",\"20160722\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"California-based medical device manufacturer Acclarent Inc., a subsidiary of Johnson & Johnson, agreed to pay $18 million to resolve allegations that the company caused health care providers to submit false claims to Medicare and other federal health care programs by marketing and distributing its sinus spacer product for use as a drug delivery device without Food and Drug Administration approval.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"JNJ\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/johnson-johnson-subsidiary-acclarent-inc-pays-government-18-million-settle-false-claims-act\",\"\"',\n '\"Advanced Medical Optics\",\"Abbott Laboratories\",\"$16,800\",\"$0\",\"$16,800\",\"2004\",\"20040412\",\"employment-related offenses\",\"labor relations violation\",\"\",\"back pay award in unfair labor practices case\",\"federal\",\"agency action\",\"National Labor Relations Board\",\"civil\",\"\",\"\",\"21-CA-36104-001\",\"\",\"\",\"California\",\"Irvine\",\"\",\"92606\",\"333314\",\"333314: Optical Instrument and Lens Manufacturing\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"Extracted from an NLRB dataset covering 1999-2011 downloaded at https://catalog.data.gov/dataset/nlrb-cats-final-c-case-data-bulk-19990101-20110930-in-xml\",\"\"',\n '\"Advanced Neuromodulation Systems, Inc.\",\"Abbott Laboratories\",\"$2,950,000\",\"$0\",\"$2,950,000\",\"2007\",\"20070702\",\"healthcare-related offenses\",\"HHS civil monetary penalties\",\"kickbacks and bribery\",\"The HHS Inspector General announced that Advanced Neuromodulation Systems, Inc.,  a medical device manufacturer specializing in spinal cord stimulation used for pain management, agreed to pay $2.95 million to settle allegations that it paid kickbacks to physicians in violation of the Civil Monetary Penalties Law (CMPL). The company also entered into a 3-year Corporate Integrity Agreement.\",\"federal\",\"agency action\",\"Health & Human Services Department Office of Inspector General\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://oig.hhs.gov/publications/docs/press/2007/ANS%20Press%20Release.pdf\",\"\"',\n '\"Advanced Sterilization Products\",\"Johnson & Johnson\",\"$136,800\",\"$0\",\"$136,800\",\"2014\",\"20140520\",\"environment-related offenses\",\"environmental violation\",\"\",\"The U.S. Environmental Protection Agency announced that an Irvine, Calif. company, Advanced Sterilization Products, has agreed to pay a $136,800 penalty for the sale and distribution of unregistered and misbranded pesticides to veterinary clinics and laboratories nationwide.\",\"federal\",\"agency action\",\"Environmental Protection Agency\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"California\",\"Irvine\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"JNJ\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://archive.epa.gov/epapages/newsroom_archive/newsreleases/8e820317c86e4c5685257cde00717855.html\",\"\"',\n '\"Advanced Sterilization Products, a division of Ethicon Inc.\",\"Johnson & Johnson\",\"$1,200,000\",\"$0\",\"$1,200,000\",\"2013\",\"20131204\",\"safety-related offenses\",\"drug or medical equipment safety violation\",\"\",\"Settlement of a civil money penalty action against Advanced Sterilization Products, a division of Ethicon Inc., a Johnson & Johnson company, and two of ASP\\'s executives alleging that ASP manufactured and distributed adulterated and misbranded sterilization monitoring products.\",\"federal\",\"agency action\",\"Food and Drug Administration\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"California\",\"Irvine\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"JNJ\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm377588.htm\",\"\"']"]}}],"execution_count":0},{"cell_type":"markdown","source":["Removing the Header of pharma (fileC) RDD"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"d50e6c88-a936-49d7-bb4b-d63b22f6355f"}}},{"cell_type":"code","source":["headerC = pharmaRDD.first()\nHeaderfileCRDD = pharmaRDD.filter(lambda line: line!= headerC)\nHeaderfileCRDD.take(10)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"e0fba384-4919-45a1-9f73-a52a488193e9"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[11]: ['\"Abbott Laboratories\",\"Abbott Laboratories\",\"$5,475,000\",\"$0\",\"$5,475,000\",\"2013\",\"20131227\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"kickbacks and bribery\",\"Abbott Laboratories agreed to $5.475 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce doctors to implant the company\\'s carotid, biliary and peripheral vascular products.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/abbott-laboratories-pays-us-5475-million-settle-claims-company-paid-kickbacks-physicians\",\"\"',\n '\"Abbott Laboratories Inc.\",\"AbbVie\",\"$1,500,000,000\",\"$0\",\"$1,500,000,000\",\"2012\",\"20120507\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company\\'s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration. The resolution - the second largest payment by a drug company - includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million. Abbott also will be subject to court-supervised probation and reporting obligations for Abbotts CEO and Board of Directors.\",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"civil and criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote\",\"\"',\n '\"Abbott Laboratories Inc.\",\"AbbVie\",\"$126,500,000\",\"$0\",\"$126,500,000\",\"2010\",\"20101207\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"Abbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories Inc. n/k/a Boehringer Ingelheim Roxane Inc. and affiliated entities agreed to pay $421 million to settle False Claims Act allegations, that they engaged in a scheme to report false and inflated prices for numerous pharmaceutical products knowing that federal healthcare programs relied on those reported prices to set payment rates.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/pharmaceutical-manufacturers-pay-4212-million-settle-false-claims-act-cases\",\"\"',\n '\"Abbott Laboratories Puerto Rico, Inc.\",\"Abbott Laboratories\",\"$49,045\",\"$0\",\"$49,045\",\"2009\",\"20090305\",\"employment-related offenses\",\"wage and hour violation\",\"Fair Labor Standards Act\",\"\",\"federal\",\"agency action\",\"Labor Department Wage and Hour Division\",\"civil\",\"\",\"\",\"1527129\",\"\",\"\",\"Puerto Rico\",\"San Juan\",\"\",\"\",\"423450\",\"423450: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"March 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\",\"Date and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\"',\n '\"Acclarent Inc.\",\"Johnson & Johnson\",\"$18,000,000\",\"$0\",\"$18,000,000\",\"2016\",\"20160722\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"California-based medical device manufacturer Acclarent Inc., a subsidiary of Johnson & Johnson, agreed to pay $18 million to resolve allegations that the company caused health care providers to submit false claims to Medicare and other federal health care programs by marketing and distributing its sinus spacer product for use as a drug delivery device without Food and Drug Administration approval.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"JNJ\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/johnson-johnson-subsidiary-acclarent-inc-pays-government-18-million-settle-false-claims-act\",\"\"',\n '\"Advanced Medical Optics\",\"Abbott Laboratories\",\"$16,800\",\"$0\",\"$16,800\",\"2004\",\"20040412\",\"employment-related offenses\",\"labor relations violation\",\"\",\"back pay award in unfair labor practices case\",\"federal\",\"agency action\",\"National Labor Relations Board\",\"civil\",\"\",\"\",\"21-CA-36104-001\",\"\",\"\",\"California\",\"Irvine\",\"\",\"92606\",\"333314\",\"333314: Optical Instrument and Lens Manufacturing\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"Extracted from an NLRB dataset covering 1999-2011 downloaded at https://catalog.data.gov/dataset/nlrb-cats-final-c-case-data-bulk-19990101-20110930-in-xml\",\"\"',\n '\"Advanced Neuromodulation Systems, Inc.\",\"Abbott Laboratories\",\"$2,950,000\",\"$0\",\"$2,950,000\",\"2007\",\"20070702\",\"healthcare-related offenses\",\"HHS civil monetary penalties\",\"kickbacks and bribery\",\"The HHS Inspector General announced that Advanced Neuromodulation Systems, Inc.,  a medical device manufacturer specializing in spinal cord stimulation used for pain management, agreed to pay $2.95 million to settle allegations that it paid kickbacks to physicians in violation of the Civil Monetary Penalties Law (CMPL). The company also entered into a 3-year Corporate Integrity Agreement.\",\"federal\",\"agency action\",\"Health & Human Services Department Office of Inspector General\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://oig.hhs.gov/publications/docs/press/2007/ANS%20Press%20Release.pdf\",\"\"',\n '\"Advanced Sterilization Products\",\"Johnson & Johnson\",\"$136,800\",\"$0\",\"$136,800\",\"2014\",\"20140520\",\"environment-related offenses\",\"environmental violation\",\"\",\"The U.S. Environmental Protection Agency announced that an Irvine, Calif. company, Advanced Sterilization Products, has agreed to pay a $136,800 penalty for the sale and distribution of unregistered and misbranded pesticides to veterinary clinics and laboratories nationwide.\",\"federal\",\"agency action\",\"Environmental Protection Agency\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"California\",\"Irvine\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"JNJ\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://archive.epa.gov/epapages/newsroom_archive/newsreleases/8e820317c86e4c5685257cde00717855.html\",\"\"',\n '\"Advanced Sterilization Products, a division of Ethicon Inc.\",\"Johnson & Johnson\",\"$1,200,000\",\"$0\",\"$1,200,000\",\"2013\",\"20131204\",\"safety-related offenses\",\"drug or medical equipment safety violation\",\"\",\"Settlement of a civil money penalty action against Advanced Sterilization Products, a division of Ethicon Inc., a Johnson & Johnson company, and two of ASP\\'s executives alleging that ASP manufactured and distributed adulterated and misbranded sterilization monitoring products.\",\"federal\",\"agency action\",\"Food and Drug Administration\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"California\",\"Irvine\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"JNJ\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm377588.htm\",\"\"',\n '\"Alere San Diego Inc.\",\"Abbott Laboratories\",\"$10,572\",\"$0\",\"$10,572\",\"2017\",\"20170309\",\"employment-related offenses\",\"wage and hour violation\",\"Fair Labor Standards Act\",\"\",\"federal\",\"agency action\",\"Labor Department Wage and Hour Division\",\"civil\",\"\",\"\",\"1813371\",\"\",\"\",\"California\",\"Pomona\",\"828 Towne Center Dr.\",\"91767\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"July 23, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\",\"Date and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\"']","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[11]: ['\"Abbott Laboratories\",\"Abbott Laboratories\",\"$5,475,000\",\"$0\",\"$5,475,000\",\"2013\",\"20131227\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"kickbacks and bribery\",\"Abbott Laboratories agreed to $5.475 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce doctors to implant the company\\'s carotid, biliary and peripheral vascular products.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/abbott-laboratories-pays-us-5475-million-settle-claims-company-paid-kickbacks-physicians\",\"\"',\n '\"Abbott Laboratories Inc.\",\"AbbVie\",\"$1,500,000,000\",\"$0\",\"$1,500,000,000\",\"2012\",\"20120507\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company\\'s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration. The resolution - the second largest payment by a drug company - includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million. Abbott also will be subject to court-supervised probation and reporting obligations for Abbotts CEO and Board of Directors.\",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"civil and criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote\",\"\"',\n '\"Abbott Laboratories Inc.\",\"AbbVie\",\"$126,500,000\",\"$0\",\"$126,500,000\",\"2010\",\"20101207\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"Abbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories Inc. n/k/a Boehringer Ingelheim Roxane Inc. and affiliated entities agreed to pay $421 million to settle False Claims Act allegations, that they engaged in a scheme to report false and inflated prices for numerous pharmaceutical products knowing that federal healthcare programs relied on those reported prices to set payment rates.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/pharmaceutical-manufacturers-pay-4212-million-settle-false-claims-act-cases\",\"\"',\n '\"Abbott Laboratories Puerto Rico, Inc.\",\"Abbott Laboratories\",\"$49,045\",\"$0\",\"$49,045\",\"2009\",\"20090305\",\"employment-related offenses\",\"wage and hour violation\",\"Fair Labor Standards Act\",\"\",\"federal\",\"agency action\",\"Labor Department Wage and Hour Division\",\"civil\",\"\",\"\",\"1527129\",\"\",\"\",\"Puerto Rico\",\"San Juan\",\"\",\"\",\"423450\",\"423450: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"March 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\",\"Date and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\"',\n '\"Acclarent Inc.\",\"Johnson & Johnson\",\"$18,000,000\",\"$0\",\"$18,000,000\",\"2016\",\"20160722\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"California-based medical device manufacturer Acclarent Inc., a subsidiary of Johnson & Johnson, agreed to pay $18 million to resolve allegations that the company caused health care providers to submit false claims to Medicare and other federal health care programs by marketing and distributing its sinus spacer product for use as a drug delivery device without Food and Drug Administration approval.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"JNJ\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/johnson-johnson-subsidiary-acclarent-inc-pays-government-18-million-settle-false-claims-act\",\"\"',\n '\"Advanced Medical Optics\",\"Abbott Laboratories\",\"$16,800\",\"$0\",\"$16,800\",\"2004\",\"20040412\",\"employment-related offenses\",\"labor relations violation\",\"\",\"back pay award in unfair labor practices case\",\"federal\",\"agency action\",\"National Labor Relations Board\",\"civil\",\"\",\"\",\"21-CA-36104-001\",\"\",\"\",\"California\",\"Irvine\",\"\",\"92606\",\"333314\",\"333314: Optical Instrument and Lens Manufacturing\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"Extracted from an NLRB dataset covering 1999-2011 downloaded at https://catalog.data.gov/dataset/nlrb-cats-final-c-case-data-bulk-19990101-20110930-in-xml\",\"\"',\n '\"Advanced Neuromodulation Systems, Inc.\",\"Abbott Laboratories\",\"$2,950,000\",\"$0\",\"$2,950,000\",\"2007\",\"20070702\",\"healthcare-related offenses\",\"HHS civil monetary penalties\",\"kickbacks and bribery\",\"The HHS Inspector General announced that Advanced Neuromodulation Systems, Inc.,  a medical device manufacturer specializing in spinal cord stimulation used for pain management, agreed to pay $2.95 million to settle allegations that it paid kickbacks to physicians in violation of the Civil Monetary Penalties Law (CMPL). The company also entered into a 3-year Corporate Integrity Agreement.\",\"federal\",\"agency action\",\"Health & Human Services Department Office of Inspector General\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://oig.hhs.gov/publications/docs/press/2007/ANS%20Press%20Release.pdf\",\"\"',\n '\"Advanced Sterilization Products\",\"Johnson & Johnson\",\"$136,800\",\"$0\",\"$136,800\",\"2014\",\"20140520\",\"environment-related offenses\",\"environmental violation\",\"\",\"The U.S. Environmental Protection Agency announced that an Irvine, Calif. company, Advanced Sterilization Products, has agreed to pay a $136,800 penalty for the sale and distribution of unregistered and misbranded pesticides to veterinary clinics and laboratories nationwide.\",\"federal\",\"agency action\",\"Environmental Protection Agency\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"California\",\"Irvine\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"JNJ\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://archive.epa.gov/epapages/newsroom_archive/newsreleases/8e820317c86e4c5685257cde00717855.html\",\"\"',\n '\"Advanced Sterilization Products, a division of Ethicon Inc.\",\"Johnson & Johnson\",\"$1,200,000\",\"$0\",\"$1,200,000\",\"2013\",\"20131204\",\"safety-related offenses\",\"drug or medical equipment safety violation\",\"\",\"Settlement of a civil money penalty action against Advanced Sterilization Products, a division of Ethicon Inc., a Johnson & Johnson company, and two of ASP\\'s executives alleging that ASP manufactured and distributed adulterated and misbranded sterilization monitoring products.\",\"federal\",\"agency action\",\"Food and Drug Administration\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"California\",\"Irvine\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"JNJ\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm377588.htm\",\"\"',\n '\"Alere San Diego Inc.\",\"Abbott Laboratories\",\"$10,572\",\"$0\",\"$10,572\",\"2017\",\"20170309\",\"employment-related offenses\",\"wage and hour violation\",\"Fair Labor Standards Act\",\"\",\"federal\",\"agency action\",\"Labor Department Wage and Hour Division\",\"civil\",\"\",\"\",\"1813371\",\"\",\"\",\"California\",\"Pomona\",\"828 Towne Center Dr.\",\"91767\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"July 23, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\",\"Date and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\"']"]}}],"execution_count":0},{"cell_type":"markdown","source":["Question 1 : Counting number of distinct studies in the dataset."],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"3099e490-3662-4d94-b071-5cc772907543"}}},{"cell_type":"code","source":["HeaderfileARDD.distinct().count()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"beaed5f7-1326-4923-85e6-e988fa197143"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[12]: 387261","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[12]: 387261"]}}],"execution_count":0},{"cell_type":"markdown","source":["Question 2: Listing all the types of studies in the dataset along with the frequencies of each type ordered from most frequent to least frequent. First the RDD was splited by the delimiter \"|\" followed by the use of lambda to map, reduceByKey and sortBy in descending order"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"0ff56b0e-2f70-4be2-830a-98a2c8ec85d8"}}},{"cell_type":"code","source":["SplitfileARDD = HeaderfileARDD.map(lambda x: (x.split (\"|\")))"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"ebfef446-0bab-48ed-bd88-fb6f421a92b9"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["TypefileARDD= SplitfileARDD.map(lambda a: (a[5],int(1)))\\\n.reduceByKey(lambda a, b: a+b)\\\n.sortBy(lambda a: a[1], ascending=False)\nTypefileARDD.collect()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"6ffbe1ac-6a55-4c50-b4df-18aaf59e1472"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[14]: [('Interventional', 301472),\n ('Observational', 77540),\n ('Observational [Patient Registry]', 8180),\n ('Expanded Access', 69)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[14]: [('Interventional', 301472),\n ('Observational', 77540),\n ('Observational [Patient Registry]', 8180),\n ('Expanded Access', 69)]"]}}],"execution_count":0},{"cell_type":"markdown","source":["Question 3: Getting the top 5 conditions (from Conditions) with their frequencies. It was first split by \",\""],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a8d70993-09cf-49e7-9949-2d2e4be131ed"}}},{"cell_type":"code","source":["fileAConditionRDD= SplitfileARDD.map(lambda a: (a[7]))\\\n.flatMap(lambda x: (x.split(\",\")))\nfileAConditionRDD.take(10)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"fc99166b-ac85-49a5-8252-56f33335dbc6"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[15]: ['',\n 'Autistic Disorder',\n 'Autism Spectrum Disorder',\n 'Diabetes Mellitus',\n 'Tuberculosis',\n 'Lung Diseases',\n 'Pulmonary Disease',\n 'Diverticular Diseases',\n 'Diverticulum',\n 'Diverticulosis']","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[15]: ['',\n 'Autistic Disorder',\n 'Autism Spectrum Disorder',\n 'Diabetes Mellitus',\n 'Tuberculosis',\n 'Lung Diseases',\n 'Pulmonary Disease',\n 'Diverticular Diseases',\n 'Diverticulum',\n 'Diverticulosis']"]}}],"execution_count":0},{"cell_type":"markdown","source":["With the use of lambda function, the conditions were filtered to remove the empty spaces, mapped and reducedByKey inorder to sort in descending order"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"986fc1fa-94dd-4a8f-85a1-50c273b6c636"}}},{"cell_type":"code","source":["EmptySpace= ['']\nFilterfileAConditionRDD=fileAConditionRDD.filter(lambda x: x not in EmptySpace)\\\n.map(lambda a: (a,1))\\\n.reduceByKey(lambda a, b: a+b)\\\n.sortBy(lambda a: a[1], ascending=False)\nFilterfileAConditionRDD.take(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"fdf5b710-718b-4c42-a17c-ba723c6a0da4"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[16]: [('Carcinoma', 13389),\n ('Diabetes Mellitus', 11080),\n ('Neoplasms', 9371),\n ('Breast Neoplasms', 8640),\n ('Syndrome', 8032)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[16]: [('Carcinoma', 13389),\n ('Diabetes Mellitus', 11080),\n ('Neoplasms', 9371),\n ('Breast Neoplasms', 8640),\n ('Syndrome', 8032)]"]}}],"execution_count":0},{"cell_type":"markdown","source":["Visualizing the top five conditions with their frquency"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"ef86f67f-e09f-4c4d-b0a9-37458c14126b"}}},{"cell_type":"code","source":["output_file(\"bars.html\")\n \nroot = FilterfileAConditionRDD.map(lambda a: a[0]).take(5)\nCount = FilterfileAConditionRDD.map(lambda a: a[1]).take(5)\n \np = figure(x_range=root, plot_height=350, title=\"Top Five Conditions\",\n           toolbar_location=None, tools=\"\")\n \np.vbar(x=root, top=Count, width=0.7)\n \np.xgrid.grid_line_color = None\np.y_range.start = 0\n \nhtml = file_html(p, CDN, \"bar\")\ndisplayHTML(html)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"adab69fb-bb1d-4e38-b863-869bef4a818f"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"\n\n\n\n<!DOCTYPE html>\n<html lang=\"en\">\n  \n  <head>\n    \n      <meta charset=\"utf-8\">\n      <title>bar</title>\n      \n      \n        \n          \n        \n        \n          \n        <script type=\"text/javascript\" src=\"https://cdn.bokeh.org/bokeh/release/bokeh-2.4.2.min.js\"></script>\n        <script type=\"text/javascript\">\n            Bokeh.set_log_level(\"info\");\n        </script>\n        \n      \n      \n    \n  </head>\n  \n  \n  <body>\n    \n      \n        \n          \n          \n            \n              <div class=\"bk-root\" id=\"71dfbe00-0314-4058-979c-23e052afd435\" data-root-id=\"1002\"></div>\n            \n          \n        \n      \n      \n        <script type=\"application/json\" id=\"1144\">\n          {\"3cf09449-9fef-40ae-a641-5d2d443b3648\":{\"defs\":[],\"roots\":{\"references\":[{\"attributes\":{\"coordinates\":null,\"formatter\":{\"id\":\"1032\"},\"group\":null,\"major_label_policy\":{\"id\":\"1033\"},\"ticker\":{\"id\":\"1014\"}},\"id\":\"1013\",\"type\":\"CategoricalAxis\"},{\"attributes\":{},\"id\":\"1011\",\"type\":\"LinearScale\"},{\"attributes\":{},\"id\":\"1014\",\"type\":\"CategoricalTicker\"},{\"attributes\":{\"factors\":[\"Carcinoma\",\"Diabetes Mellitus\",\"Neoplasms\",\"Breast Neoplasms\",\"Syndrome\"]},\"id\":\"1005\",\"type\":\"FactorRange\"},{\"attributes\":{\"axis\":{\"id\":\"1013\"},\"coordinates\":null,\"grid_line_color\":null,\"group\":null,\"ticker\":null},\"id\":\"1015\",\"type\":\"Grid\"},{\"attributes\":{},\"id\":\"1034\",\"type\":\"UnionRenderers\"},{\"attributes\":{},\"id\":\"1032\",\"type\":\"CategoricalTickFormatter\"},{\"attributes\":{},\"id\":\"1020\",\"type\":\"Toolbar\"},{\"attributes\":{\"axis\":{\"id\":\"1016\"},\"coordinates\":null,\"dimension\":1,\"group\":null,\"ticker\":null},\"id\":\"1019\",\"type\":\"Grid\"},{\"attributes\":{\"fill_color\":{\"value\":\"#1f77b4\"},\"line_color\":{\"value\":\"#1f77b4\"},\"top\":{\"field\":\"top\"},\"width\":{\"value\":0.7},\"x\":{\"field\":\"x\"}},\"id\":\"1022\",\"type\":\"VBar\"},{\"attributes\":{},\"id\":\"1017\",\"type\":\"BasicTicker\"},{\"attributes\":{\"below\":[{\"id\":\"1013\"}],\"center\":[{\"id\":\"1015\"},{\"id\":\"1019\"}],\"height\":350,\"left\":[{\"id\":\"1016\"}],\"renderers\":[{\"id\":\"1025\"}],\"title\":{\"id\":\"1003\"},\"toolbar\":{\"id\":\"1020\"},\"toolbar_location\":null,\"x_range\":{\"id\":\"1005\"},\"x_scale\":{\"id\":\"1009\"},\"y_range\":{\"id\":\"1007\"},\"y_scale\":{\"id\":\"1011\"}},\"id\":\"1002\",\"subtype\":\"Figure\",\"type\":\"Plot\"},{\"attributes\":{},\"id\":\"1030\",\"type\":\"AllLabels\"},{\"attributes\":{},\"id\":\"1035\",\"type\":\"Selection\"},{\"attributes\":{\"coordinates\":null,\"data_source\":{\"id\":\"1021\"},\"glyph\":{\"id\":\"1022\"},\"group\":null,\"hover_glyph\":null,\"muted_glyph\":{\"id\":\"1024\"},\"nonselection_glyph\":{\"id\":\"1023\"},\"view\":{\"id\":\"1026\"}},\"id\":\"1025\",\"type\":\"GlyphRenderer\"},{\"attributes\":{\"fill_alpha\":{\"value\":0.2},\"fill_color\":{\"value\":\"#1f77b4\"},\"hatch_alpha\":{\"value\":0.2},\"line_alpha\":{\"value\":0.2},\"line_color\":{\"value\":\"#1f77b4\"},\"top\":{\"field\":\"top\"},\"width\":{\"value\":0.7},\"x\":{\"field\":\"x\"}},\"id\":\"1024\",\"type\":\"VBar\"},{\"attributes\":{\"start\":0},\"id\":\"1007\",\"type\":\"DataRange1d\"},{\"attributes\":{\"source\":{\"id\":\"1021\"}},\"id\":\"1026\",\"type\":\"CDSView\"},{\"attributes\":{},\"id\":\"1009\",\"type\":\"CategoricalScale\"},{\"attributes\":{\"data\":{\"top\":[13389,11080,9371,8640,8032],\"x\":[\"Carcinoma\",\"Diabetes Mellitus\",\"Neoplasms\",\"Breast Neoplasms\",\"Syndrome\"]},\"selected\":{\"id\":\"1035\"},\"selection_policy\":{\"id\":\"1034\"}},\"id\":\"1021\",\"type\":\"ColumnDataSource\"},{\"attributes\":{},\"id\":\"1029\",\"type\":\"BasicTickFormatter\"},{\"attributes\":{\"coordinates\":null,\"group\":null,\"text\":\"Top Five Conditions\"},\"id\":\"1003\",\"type\":\"Title\"},{\"attributes\":{},\"id\":\"1033\",\"type\":\"AllLabels\"},{\"attributes\":{\"coordinates\":null,\"formatter\":{\"id\":\"1029\"},\"group\":null,\"major_label_policy\":{\"id\":\"1030\"},\"ticker\":{\"id\":\"1017\"}},\"id\":\"1016\",\"type\":\"LinearAxis\"},{\"attributes\":{\"fill_alpha\":{\"value\":0.1},\"fill_color\":{\"value\":\"#1f77b4\"},\"hatch_alpha\":{\"value\":0.1},\"line_alpha\":{\"value\":0.1},\"line_color\":{\"value\":\"#1f77b4\"},\"top\":{\"field\":\"top\"},\"width\":{\"value\":0.7},\"x\":{\"field\":\"x\"}},\"id\":\"1023\",\"type\":\"VBar\"}],\"root_ids\":[\"1002\"]},\"title\":\"Bokeh Application\",\"version\":\"2.4.2\"}}\n        </script>\n        <script type=\"text/javascript\">\n          (function() {\n            const fn = function() {\n              Bokeh.safely(function() {\n                (function(root) {\n                  function embed_document(root) {\n                    \n                  const docs_json = document.getElementById('1144').textContent;\n                  const render_items = [{\"docid\":\"3cf09449-9fef-40ae-a641-5d2d443b3648\",\"root_ids\":[\"1002\"],\"roots\":{\"1002\":\"71dfbe00-0314-4058-979c-23e052afd435\"}}];\n                  root.Bokeh.embed.embed_items(docs_json, render_items);\n                \n                  }\n                  if (root.Bokeh !== undefined) {\n                    embed_document(root);\n                  } else {\n                    let attempts = 0;\n                    const timer = setInterval(function(root) {\n                      if (root.Bokeh !== undefined) {\n                        clearInterval(timer);\n                        embed_document(root);\n                      } else {\n                        attempts++;\n                        if (attempts > 100) {\n                          clearInterval(timer);\n                          console.log(\"Bokeh: ERROR: Unable to run BokehJS code because BokehJS library is missing\");\n                        }\n                      }\n                    }, 10, root)\n                  }\n                })(window);\n              });\n            };\n            if (document.readyState != \"loading\") fn();\n            else document.addEventListener(\"DOMContentLoaded\", fn);\n          })();\n        </script>\n    \n  </body>\n  \n</html>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["\n\n\n\n<!DOCTYPE html>\n<html lang=\"en\">\n  \n  <head>\n    \n      <meta charset=\"utf-8\">\n      <title>bar</title>\n      \n      \n        \n          \n        \n        \n          \n        <script type=\"text/javascript\" src=\"https://cdn.bokeh.org/bokeh/release/bokeh-2.4.2.min.js\"></script>\n        <script type=\"text/javascript\">\n            Bokeh.set_log_level(\"info\");\n        </script>\n        \n      \n      \n    \n  </head>\n  \n  \n  <body>\n    \n      \n        \n          \n          \n            \n              <div class=\"bk-root\" id=\"71dfbe00-0314-4058-979c-23e052afd435\" data-root-id=\"1002\"></div>\n            \n          \n        \n      \n      \n        <script type=\"application/json\" id=\"1144\">\n          {\"3cf09449-9fef-40ae-a641-5d2d443b3648\":{\"defs\":[],\"roots\":{\"references\":[{\"attributes\":{\"coordinates\":null,\"formatter\":{\"id\":\"1032\"},\"group\":null,\"major_label_policy\":{\"id\":\"1033\"},\"ticker\":{\"id\":\"1014\"}},\"id\":\"1013\",\"type\":\"CategoricalAxis\"},{\"attributes\":{},\"id\":\"1011\",\"type\":\"LinearScale\"},{\"attributes\":{},\"id\":\"1014\",\"type\":\"CategoricalTicker\"},{\"attributes\":{\"factors\":[\"Carcinoma\",\"Diabetes Mellitus\",\"Neoplasms\",\"Breast Neoplasms\",\"Syndrome\"]},\"id\":\"1005\",\"type\":\"FactorRange\"},{\"attributes\":{\"axis\":{\"id\":\"1013\"},\"coordinates\":null,\"grid_line_color\":null,\"group\":null,\"ticker\":null},\"id\":\"1015\",\"type\":\"Grid\"},{\"attributes\":{},\"id\":\"1034\",\"type\":\"UnionRenderers\"},{\"attributes\":{},\"id\":\"1032\",\"type\":\"CategoricalTickFormatter\"},{\"attributes\":{},\"id\":\"1020\",\"type\":\"Toolbar\"},{\"attributes\":{\"axis\":{\"id\":\"1016\"},\"coordinates\":null,\"dimension\":1,\"group\":null,\"ticker\":null},\"id\":\"1019\",\"type\":\"Grid\"},{\"attributes\":{\"fill_color\":{\"value\":\"#1f77b4\"},\"line_color\":{\"value\":\"#1f77b4\"},\"top\":{\"field\":\"top\"},\"width\":{\"value\":0.7},\"x\":{\"field\":\"x\"}},\"id\":\"1022\",\"type\":\"VBar\"},{\"attributes\":{},\"id\":\"1017\",\"type\":\"BasicTicker\"},{\"attributes\":{\"below\":[{\"id\":\"1013\"}],\"center\":[{\"id\":\"1015\"},{\"id\":\"1019\"}],\"height\":350,\"left\":[{\"id\":\"1016\"}],\"renderers\":[{\"id\":\"1025\"}],\"title\":{\"id\":\"1003\"},\"toolbar\":{\"id\":\"1020\"},\"toolbar_location\":null,\"x_range\":{\"id\":\"1005\"},\"x_scale\":{\"id\":\"1009\"},\"y_range\":{\"id\":\"1007\"},\"y_scale\":{\"id\":\"1011\"}},\"id\":\"1002\",\"subtype\":\"Figure\",\"type\":\"Plot\"},{\"attributes\":{},\"id\":\"1030\",\"type\":\"AllLabels\"},{\"attributes\":{},\"id\":\"1035\",\"type\":\"Selection\"},{\"attributes\":{\"coordinates\":null,\"data_source\":{\"id\":\"1021\"},\"glyph\":{\"id\":\"1022\"},\"group\":null,\"hover_glyph\":null,\"muted_glyph\":{\"id\":\"1024\"},\"nonselection_glyph\":{\"id\":\"1023\"},\"view\":{\"id\":\"1026\"}},\"id\":\"1025\",\"type\":\"GlyphRenderer\"},{\"attributes\":{\"fill_alpha\":{\"value\":0.2},\"fill_color\":{\"value\":\"#1f77b4\"},\"hatch_alpha\":{\"value\":0.2},\"line_alpha\":{\"value\":0.2},\"line_color\":{\"value\":\"#1f77b4\"},\"top\":{\"field\":\"top\"},\"width\":{\"value\":0.7},\"x\":{\"field\":\"x\"}},\"id\":\"1024\",\"type\":\"VBar\"},{\"attributes\":{\"start\":0},\"id\":\"1007\",\"type\":\"DataRange1d\"},{\"attributes\":{\"source\":{\"id\":\"1021\"}},\"id\":\"1026\",\"type\":\"CDSView\"},{\"attributes\":{},\"id\":\"1009\",\"type\":\"CategoricalScale\"},{\"attributes\":{\"data\":{\"top\":[13389,11080,9371,8640,8032],\"x\":[\"Carcinoma\",\"Diabetes Mellitus\",\"Neoplasms\",\"Breast Neoplasms\",\"Syndrome\"]},\"selected\":{\"id\":\"1035\"},\"selection_policy\":{\"id\":\"1034\"}},\"id\":\"1021\",\"type\":\"ColumnDataSource\"},{\"attributes\":{},\"id\":\"1029\",\"type\":\"BasicTickFormatter\"},{\"attributes\":{\"coordinates\":null,\"group\":null,\"text\":\"Top Five Conditions\"},\"id\":\"1003\",\"type\":\"Title\"},{\"attributes\":{},\"id\":\"1033\",\"type\":\"AllLabels\"},{\"attributes\":{\"coordinates\":null,\"formatter\":{\"id\":\"1029\"},\"group\":null,\"major_label_policy\":{\"id\":\"1030\"},\"ticker\":{\"id\":\"1017\"}},\"id\":\"1016\",\"type\":\"LinearAxis\"},{\"attributes\":{\"fill_alpha\":{\"value\":0.1},\"fill_color\":{\"value\":\"#1f77b4\"},\"hatch_alpha\":{\"value\":0.1},\"line_alpha\":{\"value\":0.1},\"line_color\":{\"value\":\"#1f77b4\"},\"top\":{\"field\":\"top\"},\"width\":{\"value\":0.7},\"x\":{\"field\":\"x\"}},\"id\":\"1023\",\"type\":\"VBar\"}],\"root_ids\":[\"1002\"]},\"title\":\"Bokeh Application\",\"version\":\"2.4.2\"}}\n        </script>\n        <script type=\"text/javascript\">\n          (function() {\n            const fn = function() {\n              Bokeh.safely(function() {\n                (function(root) {\n                  function embed_document(root) {\n                    \n                  const docs_json = document.getElementById('1144').textContent;\n                  const render_items = [{\"docid\":\"3cf09449-9fef-40ae-a641-5d2d443b3648\",\"root_ids\":[\"1002\"],\"roots\":{\"1002\":\"71dfbe00-0314-4058-979c-23e052afd435\"}}];\n                  root.Bokeh.embed.embed_items(docs_json, render_items);\n                \n                  }\n                  if (root.Bokeh !== undefined) {\n                    embed_document(root);\n                  } else {\n                    let attempts = 0;\n                    const timer = setInterval(function(root) {\n                      if (root.Bokeh !== undefined) {\n                        clearInterval(timer);\n                        embed_document(root);\n                      } else {\n                        attempts++;\n                        if (attempts > 100) {\n                          clearInterval(timer);\n                          console.log(\"Bokeh: ERROR: Unable to run BokehJS code because BokehJS library is missing\");\n                        }\n                      }\n                    }, 10, root)\n                  }\n                })(window);\n              });\n            };\n            if (document.readyState != \"loading\") fn();\n            else document.addEventListener(\"DOMContentLoaded\", fn);\n          })();\n        </script>\n    \n  </body>\n  \n</html>"]}}],"execution_count":0},{"cell_type":"markdown","source":["Question 4: Getting the 5 most frequent roots after mapping each condition to one or more hierarchy codes, First the Spliting of mesh (fileB) RDD by the delimiter \",\""],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"73b15e75-7129-42df-982d-d3d6c9a2ed4d"}}},{"cell_type":"code","source":["SplitfileBRDD=HeaderfileBRDD.map(lambda row: (row.split(\",\")))\nSplitfileBRDD.take(10)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"709fbb20-b10e-45cf-9a66-a0021046f30f"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[18]: [['Calcimycin', 'D03.633.100.221.173'],\n ['A-23187', 'D03.633.100.221.173'],\n ['Temefos', 'D02.705.400.625.800'],\n ['Temefos', 'D02.705.539.345.800'],\n ['Temefos', 'D02.886.300.692.800'],\n ['Abate', 'D02.705.400.625.800'],\n ['Abate', 'D02.705.539.345.800'],\n ['Abate', 'D02.886.300.692.800'],\n ['Difos', 'D02.705.400.625.800'],\n ['Difos', 'D02.705.539.345.800']]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[18]: [['Calcimycin', 'D03.633.100.221.173'],\n ['A-23187', 'D03.633.100.221.173'],\n ['Temefos', 'D02.705.400.625.800'],\n ['Temefos', 'D02.705.539.345.800'],\n ['Temefos', 'D02.886.300.692.800'],\n ['Abate', 'D02.705.400.625.800'],\n ['Abate', 'D02.705.539.345.800'],\n ['Abate', 'D02.886.300.692.800'],\n ['Difos', 'D02.705.400.625.800'],\n ['Difos', 'D02.705.539.345.800']]"]}}],"execution_count":0},{"cell_type":"markdown","source":["Joining fileA(clinicaltrials) with fileB(Mesh), mapping the content, spliting with \".\", reducing by key to sum their frequencies and then sorting by the most frequent roots"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"46882582-cd29-4691-9016-14fc50854f9a"}}},{"cell_type":"code","source":["fileAfileBJoin=FilterfileAConditionRDD.join(SplitfileBRDD)\\\n.map(lambda a: (a[1]))\\\n.map(lambda a: (a[1],a[0]))\\\n.map(lambda a: (a[0].split('.')[0],a[1]))\\\n.reduceByKey(lambda a,b: a+b )\\\n.sortBy(lambda a: a[1], ascending=False)\nfileAfileBJoin.take(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a7f93785-15b2-4d0d-a378-5952c7c02bcd"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[19]: [('C04', 143994),\n ('C23', 136079),\n ('C01', 106674),\n ('C14', 94523),\n ('C10', 92310)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[19]: [('C04', 143994),\n ('C23', 136079),\n ('C01', 106674),\n ('C14', 94523),\n ('C10', 92310)]"]}}],"execution_count":0},{"cell_type":"markdown","source":["Visualizing the result using bokeh bar chart earlier imported"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"29248b77-7e56-4051-b59f-f10668dd0e81"}}},{"cell_type":"code","source":["output_file(\"bars.html\")\n \nroot = fileAfileBJoin.map(lambda a: a[0]).take(5)\nCount = fileAfileBJoin.map(lambda a: a[1]).take(5)\n \np = figure(x_range=root, plot_height=350, title=\"Five Most Frequent Roots\",\n           toolbar_location=None, tools=\"\")\n \np.vbar(x=root, top=Count, width=0.7)\n \np.xgrid.grid_line_color = None\np.y_range.start = 0\n \nhtml = file_html(p, CDN, \"bar\")\ndisplayHTML(html)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"4673f411-36c2-4ce5-9241-419fab8406eb"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"\n\n\n\n<!DOCTYPE html>\n<html lang=\"en\">\n  \n  <head>\n    \n      <meta charset=\"utf-8\">\n      <title>bar</title>\n      \n      \n        \n          \n        \n        \n          \n        <script type=\"text/javascript\" src=\"https://cdn.bokeh.org/bokeh/release/bokeh-2.4.2.min.js\"></script>\n        <script type=\"text/javascript\">\n            Bokeh.set_log_level(\"info\");\n        </script>\n        \n      \n      \n    \n  </head>\n  \n  \n  <body>\n    \n      \n        \n          \n          \n            \n              <div class=\"bk-root\" id=\"88afa260-7fa2-4ef0-ab62-6acd63956900\" data-root-id=\"1145\"></div>\n            \n          \n        \n      \n      \n        <script type=\"application/json\" id=\"1287\">\n          {\"de292c4f-8470-4a03-a8ba-d9332bf5413f\":{\"defs\":[],\"roots\":{\"references\":[{\"attributes\":{},\"id\":\"1175\",\"type\":\"CategoricalTickFormatter\"},{\"attributes\":{\"fill_color\":{\"value\":\"#1f77b4\"},\"line_color\":{\"value\":\"#1f77b4\"},\"top\":{\"field\":\"top\"},\"width\":{\"value\":0.7},\"x\":{\"field\":\"x\"}},\"id\":\"1165\",\"type\":\"VBar\"},{\"attributes\":{},\"id\":\"1160\",\"type\":\"BasicTicker\"},{\"attributes\":{},\"id\":\"1157\",\"type\":\"CategoricalTicker\"},{\"attributes\":{},\"id\":\"1178\",\"type\":\"Selection\"},{\"attributes\":{\"factors\":[\"C04\",\"C23\",\"C01\",\"C14\",\"C10\"]},\"id\":\"1148\",\"type\":\"FactorRange\"},{\"attributes\":{},\"id\":\"1176\",\"type\":\"AllLabels\"},{\"attributes\":{\"coordinates\":null,\"formatter\":{\"id\":\"1172\"},\"group\":null,\"major_label_policy\":{\"id\":\"1173\"},\"ticker\":{\"id\":\"1160\"}},\"id\":\"1159\",\"type\":\"LinearAxis\"},{\"attributes\":{\"fill_alpha\":{\"value\":0.2},\"fill_color\":{\"value\":\"#1f77b4\"},\"hatch_alpha\":{\"value\":0.2},\"line_alpha\":{\"value\":0.2},\"line_color\":{\"value\":\"#1f77b4\"},\"top\":{\"field\":\"top\"},\"width\":{\"value\":0.7},\"x\":{\"field\":\"x\"}},\"id\":\"1167\",\"type\":\"VBar\"},{\"attributes\":{\"data\":{\"top\":[143994,136079,106674,94523,92310],\"x\":[\"C04\",\"C23\",\"C01\",\"C14\",\"C10\"]},\"selected\":{\"id\":\"1178\"},\"selection_policy\":{\"id\":\"1177\"}},\"id\":\"1164\",\"type\":\"ColumnDataSource\"},{\"attributes\":{},\"id\":\"1172\",\"type\":\"BasicTickFormatter\"},{\"attributes\":{\"coordinates\":null,\"formatter\":{\"id\":\"1175\"},\"group\":null,\"major_label_policy\":{\"id\":\"1176\"},\"ticker\":{\"id\":\"1157\"}},\"id\":\"1156\",\"type\":\"CategoricalAxis\"},{\"attributes\":{},\"id\":\"1177\",\"type\":\"UnionRenderers\"},{\"attributes\":{},\"id\":\"1163\",\"type\":\"Toolbar\"},{\"attributes\":{\"below\":[{\"id\":\"1156\"}],\"center\":[{\"id\":\"1158\"},{\"id\":\"1162\"}],\"height\":350,\"left\":[{\"id\":\"1159\"}],\"renderers\":[{\"id\":\"1168\"}],\"title\":{\"id\":\"1146\"},\"toolbar\":{\"id\":\"1163\"},\"toolbar_location\":null,\"x_range\":{\"id\":\"1148\"},\"x_scale\":{\"id\":\"1152\"},\"y_range\":{\"id\":\"1150\"},\"y_scale\":{\"id\":\"1154\"}},\"id\":\"1145\",\"subtype\":\"Figure\",\"type\":\"Plot\"},{\"attributes\":{\"coordinates\":null,\"group\":null,\"text\":\"Five Most Frequent Roots\"},\"id\":\"1146\",\"type\":\"Title\"},{\"attributes\":{\"source\":{\"id\":\"1164\"}},\"id\":\"1169\",\"type\":\"CDSView\"},{\"attributes\":{\"coordinates\":null,\"data_source\":{\"id\":\"1164\"},\"glyph\":{\"id\":\"1165\"},\"group\":null,\"hover_glyph\":null,\"muted_glyph\":{\"id\":\"1167\"},\"nonselection_glyph\":{\"id\":\"1166\"},\"view\":{\"id\":\"1169\"}},\"id\":\"1168\",\"type\":\"GlyphRenderer\"},{\"attributes\":{\"start\":0},\"id\":\"1150\",\"type\":\"DataRange1d\"},{\"attributes\":{\"axis\":{\"id\":\"1156\"},\"coordinates\":null,\"grid_line_color\":null,\"group\":null,\"ticker\":null},\"id\":\"1158\",\"type\":\"Grid\"},{\"attributes\":{},\"id\":\"1173\",\"type\":\"AllLabels\"},{\"attributes\":{\"axis\":{\"id\":\"1159\"},\"coordinates\":null,\"dimension\":1,\"group\":null,\"ticker\":null},\"id\":\"1162\",\"type\":\"Grid\"},{\"attributes\":{},\"id\":\"1154\",\"type\":\"LinearScale\"},{\"attributes\":{\"fill_alpha\":{\"value\":0.1},\"fill_color\":{\"value\":\"#1f77b4\"},\"hatch_alpha\":{\"value\":0.1},\"line_alpha\":{\"value\":0.1},\"line_color\":{\"value\":\"#1f77b4\"},\"top\":{\"field\":\"top\"},\"width\":{\"value\":0.7},\"x\":{\"field\":\"x\"}},\"id\":\"1166\",\"type\":\"VBar\"},{\"attributes\":{},\"id\":\"1152\",\"type\":\"CategoricalScale\"}],\"root_ids\":[\"1145\"]},\"title\":\"Bokeh Application\",\"version\":\"2.4.2\"}}\n        </script>\n        <script type=\"text/javascript\">\n          (function() {\n            const fn = function() {\n              Bokeh.safely(function() {\n                (function(root) {\n                  function embed_document(root) {\n                    \n                  const docs_json = document.getElementById('1287').textContent;\n                  const render_items = [{\"docid\":\"de292c4f-8470-4a03-a8ba-d9332bf5413f\",\"root_ids\":[\"1145\"],\"roots\":{\"1145\":\"88afa260-7fa2-4ef0-ab62-6acd63956900\"}}];\n                  root.Bokeh.embed.embed_items(docs_json, render_items);\n                \n                  }\n                  if (root.Bokeh !== undefined) {\n                    embed_document(root);\n                  } else {\n                    let attempts = 0;\n                    const timer = setInterval(function(root) {\n                      if (root.Bokeh !== undefined) {\n                        clearInterval(timer);\n                        embed_document(root);\n                      } else {\n                        attempts++;\n                        if (attempts > 100) {\n                          clearInterval(timer);\n                          console.log(\"Bokeh: ERROR: Unable to run BokehJS code because BokehJS library is missing\");\n                        }\n                      }\n                    }, 10, root)\n                  }\n                })(window);\n              });\n            };\n            if (document.readyState != \"loading\") fn();\n            else document.addEventListener(\"DOMContentLoaded\", fn);\n          })();\n        </script>\n    \n  </body>\n  \n</html>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["\n\n\n\n<!DOCTYPE html>\n<html lang=\"en\">\n  \n  <head>\n    \n      <meta charset=\"utf-8\">\n      <title>bar</title>\n      \n      \n        \n          \n        \n        \n          \n        <script type=\"text/javascript\" src=\"https://cdn.bokeh.org/bokeh/release/bokeh-2.4.2.min.js\"></script>\n        <script type=\"text/javascript\">\n            Bokeh.set_log_level(\"info\");\n        </script>\n        \n      \n      \n    \n  </head>\n  \n  \n  <body>\n    \n      \n        \n          \n          \n            \n              <div class=\"bk-root\" id=\"88afa260-7fa2-4ef0-ab62-6acd63956900\" data-root-id=\"1145\"></div>\n            \n          \n        \n      \n      \n        <script type=\"application/json\" id=\"1287\">\n          {\"de292c4f-8470-4a03-a8ba-d9332bf5413f\":{\"defs\":[],\"roots\":{\"references\":[{\"attributes\":{},\"id\":\"1175\",\"type\":\"CategoricalTickFormatter\"},{\"attributes\":{\"fill_color\":{\"value\":\"#1f77b4\"},\"line_color\":{\"value\":\"#1f77b4\"},\"top\":{\"field\":\"top\"},\"width\":{\"value\":0.7},\"x\":{\"field\":\"x\"}},\"id\":\"1165\",\"type\":\"VBar\"},{\"attributes\":{},\"id\":\"1160\",\"type\":\"BasicTicker\"},{\"attributes\":{},\"id\":\"1157\",\"type\":\"CategoricalTicker\"},{\"attributes\":{},\"id\":\"1178\",\"type\":\"Selection\"},{\"attributes\":{\"factors\":[\"C04\",\"C23\",\"C01\",\"C14\",\"C10\"]},\"id\":\"1148\",\"type\":\"FactorRange\"},{\"attributes\":{},\"id\":\"1176\",\"type\":\"AllLabels\"},{\"attributes\":{\"coordinates\":null,\"formatter\":{\"id\":\"1172\"},\"group\":null,\"major_label_policy\":{\"id\":\"1173\"},\"ticker\":{\"id\":\"1160\"}},\"id\":\"1159\",\"type\":\"LinearAxis\"},{\"attributes\":{\"fill_alpha\":{\"value\":0.2},\"fill_color\":{\"value\":\"#1f77b4\"},\"hatch_alpha\":{\"value\":0.2},\"line_alpha\":{\"value\":0.2},\"line_color\":{\"value\":\"#1f77b4\"},\"top\":{\"field\":\"top\"},\"width\":{\"value\":0.7},\"x\":{\"field\":\"x\"}},\"id\":\"1167\",\"type\":\"VBar\"},{\"attributes\":{\"data\":{\"top\":[143994,136079,106674,94523,92310],\"x\":[\"C04\",\"C23\",\"C01\",\"C14\",\"C10\"]},\"selected\":{\"id\":\"1178\"},\"selection_policy\":{\"id\":\"1177\"}},\"id\":\"1164\",\"type\":\"ColumnDataSource\"},{\"attributes\":{},\"id\":\"1172\",\"type\":\"BasicTickFormatter\"},{\"attributes\":{\"coordinates\":null,\"formatter\":{\"id\":\"1175\"},\"group\":null,\"major_label_policy\":{\"id\":\"1176\"},\"ticker\":{\"id\":\"1157\"}},\"id\":\"1156\",\"type\":\"CategoricalAxis\"},{\"attributes\":{},\"id\":\"1177\",\"type\":\"UnionRenderers\"},{\"attributes\":{},\"id\":\"1163\",\"type\":\"Toolbar\"},{\"attributes\":{\"below\":[{\"id\":\"1156\"}],\"center\":[{\"id\":\"1158\"},{\"id\":\"1162\"}],\"height\":350,\"left\":[{\"id\":\"1159\"}],\"renderers\":[{\"id\":\"1168\"}],\"title\":{\"id\":\"1146\"},\"toolbar\":{\"id\":\"1163\"},\"toolbar_location\":null,\"x_range\":{\"id\":\"1148\"},\"x_scale\":{\"id\":\"1152\"},\"y_range\":{\"id\":\"1150\"},\"y_scale\":{\"id\":\"1154\"}},\"id\":\"1145\",\"subtype\":\"Figure\",\"type\":\"Plot\"},{\"attributes\":{\"coordinates\":null,\"group\":null,\"text\":\"Five Most Frequent Roots\"},\"id\":\"1146\",\"type\":\"Title\"},{\"attributes\":{\"source\":{\"id\":\"1164\"}},\"id\":\"1169\",\"type\":\"CDSView\"},{\"attributes\":{\"coordinates\":null,\"data_source\":{\"id\":\"1164\"},\"glyph\":{\"id\":\"1165\"},\"group\":null,\"hover_glyph\":null,\"muted_glyph\":{\"id\":\"1167\"},\"nonselection_glyph\":{\"id\":\"1166\"},\"view\":{\"id\":\"1169\"}},\"id\":\"1168\",\"type\":\"GlyphRenderer\"},{\"attributes\":{\"start\":0},\"id\":\"1150\",\"type\":\"DataRange1d\"},{\"attributes\":{\"axis\":{\"id\":\"1156\"},\"coordinates\":null,\"grid_line_color\":null,\"group\":null,\"ticker\":null},\"id\":\"1158\",\"type\":\"Grid\"},{\"attributes\":{},\"id\":\"1173\",\"type\":\"AllLabels\"},{\"attributes\":{\"axis\":{\"id\":\"1159\"},\"coordinates\":null,\"dimension\":1,\"group\":null,\"ticker\":null},\"id\":\"1162\",\"type\":\"Grid\"},{\"attributes\":{},\"id\":\"1154\",\"type\":\"LinearScale\"},{\"attributes\":{\"fill_alpha\":{\"value\":0.1},\"fill_color\":{\"value\":\"#1f77b4\"},\"hatch_alpha\":{\"value\":0.1},\"line_alpha\":{\"value\":0.1},\"line_color\":{\"value\":\"#1f77b4\"},\"top\":{\"field\":\"top\"},\"width\":{\"value\":0.7},\"x\":{\"field\":\"x\"}},\"id\":\"1166\",\"type\":\"VBar\"},{\"attributes\":{},\"id\":\"1152\",\"type\":\"CategoricalScale\"}],\"root_ids\":[\"1145\"]},\"title\":\"Bokeh Application\",\"version\":\"2.4.2\"}}\n        </script>\n        <script type=\"text/javascript\">\n          (function() {\n            const fn = function() {\n              Bokeh.safely(function() {\n                (function(root) {\n                  function embed_document(root) {\n                    \n                  const docs_json = document.getElementById('1287').textContent;\n                  const render_items = [{\"docid\":\"de292c4f-8470-4a03-a8ba-d9332bf5413f\",\"root_ids\":[\"1145\"],\"roots\":{\"1145\":\"88afa260-7fa2-4ef0-ab62-6acd63956900\"}}];\n                  root.Bokeh.embed.embed_items(docs_json, render_items);\n                \n                  }\n                  if (root.Bokeh !== undefined) {\n                    embed_document(root);\n                  } else {\n                    let attempts = 0;\n                    const timer = setInterval(function(root) {\n                      if (root.Bokeh !== undefined) {\n                        clearInterval(timer);\n                        embed_document(root);\n                      } else {\n                        attempts++;\n                        if (attempts > 100) {\n                          clearInterval(timer);\n                          console.log(\"Bokeh: ERROR: Unable to run BokehJS code because BokehJS library is missing\");\n                        }\n                      }\n                    }, 10, root)\n                  }\n                })(window);\n              });\n            };\n            if (document.readyState != \"loading\") fn();\n            else document.addEventListener(\"DOMContentLoaded\", fn);\n          })();\n        </script>\n    \n  </body>\n  \n</html>"]}}],"execution_count":0},{"cell_type":"markdown","source":["Question 5: Getting 10 most common sponsors that are not pharmaceutical companies, along with the number of clinical trials they have sponsored. First the Spliting of pharma (fileC) RDD by the delimiter \",\", mapping and reducingByKey"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"6a88ed07-cb59-4764-aba6-6be1bc714898"}}},{"cell_type":"code","source":["FinalfileCRDD= HeaderfileCRDD.map(lambda line: line.replace('\"','').split(',')[1])\\\n.map(lambda a: (a,1))\\\n.reduceByKey(lambda a,b: a+b)\nFinalfileCRDD.take(10)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"4c004636-f848-4022-893c-ba817d5a79be"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[21]: [('Abbott Laboratories', 26),\n ('AbbVie', 38),\n (' LLC', 26),\n ('AstraZeneca', 22),\n ('Sanofi', 24),\n ('AVEO Pharmaceuticals', 1),\n ('Bausch Health', 11),\n ('GlaxoSmithKline', 31),\n ('Teva Pharmaceutical Industries', 36),\n ('Merck', 64)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[21]: [('Abbott Laboratories', 26),\n ('AbbVie', 38),\n (' LLC', 26),\n ('AstraZeneca', 22),\n ('Sanofi', 24),\n ('AVEO Pharmaceuticals', 1),\n ('Bausch Health', 11),\n ('GlaxoSmithKline', 31),\n ('Teva Pharmaceutical Industries', 36),\n ('Merck', 64)]"]}}],"execution_count":0},{"cell_type":"markdown","source":["Joining the clinicaltrail with the pharma file, reducingByKey to get their frequencies and sorting in descending order"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"af83efcf-9c53-4d1e-873a-a5e7b93babed"}}},{"cell_type":"code","source":["SponsorfileAMapRDD= SplitfileARDD.map(lambda a:a[1])\\\n.map(lambda a: (a,1))\\\n.reduceByKey(lambda a,b: a+b)\\\n.subtractByKey(FinalfileCRDD)\\\n.sortBy(lambda a: a[1], ascending=False)\nSponsorfileAMapRDD.take(10)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"dff7e1f5-382b-48bd-944b-7942a3d36db2"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[22]: [('National Cancer Institute (NCI)', 3218),\n ('M.D. Anderson Cancer Center', 2414),\n ('Assistance Publique - Hpitaux de Paris', 2369),\n ('Mayo Clinic', 2300),\n ('Merck Sharp & Dohme Corp.', 2243),\n ('Assiut University', 2154),\n ('Novartis Pharmaceuticals', 2088),\n ('Massachusetts General Hospital', 1971),\n ('Cairo University', 1928),\n ('Hoffmann-La Roche', 1828)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[22]: [('National Cancer Institute (NCI)', 3218),\n ('M.D. Anderson Cancer Center', 2414),\n ('Assistance Publique - Hpitaux de Paris', 2369),\n ('Mayo Clinic', 2300),\n ('Merck Sharp & Dohme Corp.', 2243),\n ('Assiut University', 2154),\n ('Novartis Pharmaceuticals', 2088),\n ('Massachusetts General Hospital', 1971),\n ('Cairo University', 1928),\n ('Hoffmann-La Roche', 1828)]"]}}],"execution_count":0},{"cell_type":"markdown","source":["Using the imported matplot to visualize the ten most common sponsors"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"cbb18f0f-3877-42aa-aaf0-c00cc7eedea0"}}},{"cell_type":"code","source":["   # initializing the data\nx = SponsorfileAMapRDD.map(lambda a: a[0]).take(10)\ny = SponsorfileAMapRDD.map(lambda a: a[1]).take(10)\n   # plotting the data\nplt.plot(x, y)\n   # Adding the title\nplt.title(\"Ten Most Common Sponsors\")\n   # Adding the labels \nplt.plot(x, y)\nplt.xticks(rotation=90)\nplt.show()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"b6cedfaf-84b7-4f64-b880-b728e7636144"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"data:image/png;base64,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\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"image","arguments":{}}},"output_type":"display_data","data":{"image/png":"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\n"}}],"execution_count":0},{"cell_type":"markdown","source":["Question 6: Plot number of completed studies each month in a given year, the split clinicaltrials RDD was mapped and filtered to get the studies completed in the year under review. It was further reducedByKey to get the counts in each month"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"91279017-8517-4c22-b254-6675177107e6"}}},{"cell_type":"code","source":["MonthbyMonthRDD= SplitfileARDD.map(lambda a: (a[2],a[4]))\\\n.filter(lambda a: year in a[1])\\\n.filter(lambda a: 'Completed' in a[0])\\\n.map(lambda a: (a[1],1))\\\n.reduceByKey(lambda a, b: a+b)\\\n.map(lambda a: (a[0].split(' ')[0],a[1]))\\\n.sortByKey(ascending = False)\\\n.map(lambda a: (a[0],a[1]))\nMonthbyMonthRDD.take(12)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a664b049-d1bb-4051-b83d-7bb297cea873"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[24]: [('Sep', 528),\n ('Oct', 187),\n ('May', 984),\n ('Mar', 1227),\n ('Jun', 1094),\n ('Jul', 819),\n ('Jan', 1131),\n ('Feb', 934),\n ('Aug', 700),\n ('Apr', 967)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[24]: [('Sep', 528),\n ('Oct', 187),\n ('May', 984),\n ('Mar', 1227),\n ('Jun', 1094),\n ('Jul', 819),\n ('Jan', 1131),\n ('Feb', 934),\n ('Aug', 700),\n ('Apr', 967)]"]}}],"execution_count":0},{"cell_type":"markdown","source":["Using the imported calender to sort the months in  chronological order"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"9abfc278-4b3c-4e03-940e-9088b48a653f"}}},{"cell_type":"code","source":["d = {i:e for e,i in enumerate(calendar.month_abbr[1:],1)}\n\n#{'Jan': 1, 'Feb': 2, 'Mar': 3, 'Apr': 4, 'May': 5, 'Jun': 6, 'Jul': 7, \n#'Aug': 8, 'Sep': 9, 'Oct': 10, 'Nov': 11, 'Dec': 12}\n\nMonthlyRDD=MonthbyMonthRDD.sortBy(keyfunc=lambda x: d.get(x[0]))\nMonthlyRDD.collect()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"4d6c40c1-f5cc-4556-b594-a6b4eece7f0a"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[25]: [('Jan', 1131),\n ('Feb', 934),\n ('Mar', 1227),\n ('Apr', 967),\n ('May', 984),\n ('Jun', 1094),\n ('Jul', 819),\n ('Aug', 700),\n ('Sep', 528),\n ('Oct', 187)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[25]: [('Jan', 1131),\n ('Feb', 934),\n ('Mar', 1227),\n ('Apr', 967),\n ('May', 984),\n ('Jun', 1094),\n ('Jul', 819),\n ('Aug', 700),\n ('Sep', 528),\n ('Oct', 187)]"]}}],"execution_count":0}],"metadata":{"application/vnd.databricks.v1+notebook":{"notebookName":"Oguike_rdd","dashboards":[],"notebookMetadata":{"pythonIndentUnit":4},"language":"python","widgets":{},"notebookOrigID":539793453292382}},"nbformat":4,"nbformat_minor":0}
